Processing 00000000.tx.1: Interferon- as a Mediator of Polyinosinic:Polycytidylic AcidInduced Type 1 Diabetes Devasenan Devendra, Jean Jasinski, Evie Melanitou, Maki Nakayama, Marcella Li, Brooke Hensley, Johanna Paronen, Hiroaki Moriyama, Dongmei Miao, George S. 

Phrase: "Interferon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "a Mediator of Polyinosinic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "Polycytidylic AcidInduced Type 1 Diabetes Devasenan Devendra,"

Phrase: "Jean Jasinski,"

Phrase: "Evie Melanitou,"

Phrase: "Maki Nakayama,"

Phrase: "Marcella Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Brooke Hensley,"

Phrase: "Johanna Paronen,"

Phrase: "Hiroaki Moriyama,"

Phrase: "Dongmei Miao,"

Phrase: "George S."
Processing 00000000.tx.2: Eisenbarth, and Edwin Liu From the Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado  ABSTRACT TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  A number of studies and clinical case reports have implicated interferon (IFN)- as a potential mediator of type 1 diabetes pathogenesis. 

Phrase: "Eisenbarth,"

Phrase: "and"

Phrase: "Edwin Liu From the Barbara Davis"

Phrase: "Center for Childhood Diabetes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]
   770   C0205099:Center [Spatial Concept]
   770   C0231335:Childhood [Temporal Concept]

Phrase: "University of Colorado Health Sciences Center,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   839   C0475309:Health center [Health Care Related Organization,Manufactured Object]
   827   C1512352:Health Sciences [Biomedical Occupation or Discipline]
   799   C0009399:Colorado [Geographic Area]
   799   C0018684:Health [Idea or Concept]
   799   C0036397:Sciences [Occupation or Discipline]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0205099:Center [Spatial Concept]

Phrase: "Denver,"

Phrase: "Colorado  ABSTRACT TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A number of studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "clinical case reports"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   913   C1299495:clinical reports [Intellectual Product]
   901   C0007320:Case Reports [Intellectual Product]
   867 E C0085973:Case Report [Intellectual Product]
   827   C0684224:Reports [Intellectual Product]
   827   C0700287:reports [Health Care Activity]
   827   C0868928:Case [Functional Concept]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]
   793 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "implicated interferon (IFN)-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "a potential mediator of type 1 diabetes pathogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.3: Administration of polyinosinic:polycytidylic acid (poly I:C), a mimic of viral double-stranded RNA, induces diabetes in C57BL/6 mice expressing the B7.1 costimulatory molecule in islets. 

Phrase: "Administration of polyinosinic:polycytidylic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001554:Administration [Occupational Activity]
   760   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "(poly I:C),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "a"

Phrase: "mimic of viral double-stranded RNA,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0035693:RNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   783   C0035736:RNA, Viral [Nucleic Acid, Nucleoside, or Nucleotide]
   754   C1979882:Double strand [Qualitative Concept]
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205173:Double [Functional Concept]
   753   C0521026:Viral [Functional Concept]
   753   C1705764:Double [Activity]
   753   C1705765:Double [Qualitative Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "diabetes in C57BL/6 mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]

Phrase: "expressing"

Phrase: "the B7.1 costimulatory molecule in islets."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0104998:B7-1 Costimulatory Molecule [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C2985420:Costimulatory Molecule [Amino Acid, Peptide, or Protein]
   748   C0567416:Molecule [Substance]
Processing 00000000.tx.4: We investigated the potential role of IFN- in this disease model. 

Phrase: "We"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the potential role of IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in this disease model."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683033:disease model [Intellectual Product]
  1000   C0684309:Disease model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]
Processing 00000000.tx.5: The quantitative correlation between IFN- levels and time to diabetes, diabetes prevention with antiIFN- antibody, and ability of IFN- itself to induce diabetes are consistent with the hypothesis that poly I:C in this model acts by induction of IFN- in a genetically susceptible host. 

Phrase: "The quantitative correlation between IFN- levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "time to diabetes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040223:Time [Temporal Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "diabetes prevention with antiIFN- antibody,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1659987:diabetes prevention [Educational Activity]
   760   C0199176:Prevention [Therapeutic or Preventive Procedure]
   760   C1706420:PREVENTION [Research Activity]
   760   C2700409:prevention [Qualitative Concept]

Phrase: "and"

Phrase: "ability of IFN-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0085732:Ability [Organism Attribute]
   718 E C1299581:Able [Finding]

Phrase: "itself to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "are"

Phrase: "consistent with the hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that poly I:C in this model"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   778   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   774   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0021966:I- [Inorganic Chemical]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "acts by induction of IFN-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0205263:Induction [Functional Concept]
   760   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in a genetically susceptible host."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1167395:Host [Organism]
Processing 00000000.tx.6: Numerous recent studies highlight the importance of the innate immune system and toll receptors in determining adaptive immune responses, and we speculate that for type 1 diabetes, viral and other environmental factors may act through induction of IFNs. 

Phrase: "Numerous recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "highlight"

Phrase: "the importance of the innate immune system"

Phrase: "and"

Phrase: "toll receptors in determining adaptive immune responses,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0034817:immune receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   748   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "we"

Phrase: "speculate"

Phrase: "that for type 1 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0011854:Type 1 diabetes [Disease or Syndrome]
   806   C0441729:Type 1 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "viral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521026:Viral [Functional Concept]

Phrase: "and"

Phrase: "other environmental factors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "act through induction of IFNs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.7: Type 1A diabetes results from T-cellmediated destruction of -cells in the pancreas with evidence of islet-specific autoimmunity (13). 

Phrase: "Type 1A diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1320657:type diabetes [Finding]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]

Phrase: "results from T-cellmediated destruction of -cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   748   C0007634:Cells [Cell]
   748   C1261381:Destruction [Therapeutic or Preventive Procedure]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1948029:Destruction [Activity]
   748   C2825142:Result [Finding]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "in the pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "with evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "of islet-specific autoimmunity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0004368:Autoimmunity [Pathologic Function]
   755 E C0443146:Autoimmune [Pathologic Function]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.8: Both genetic and environmental factors appear to play an important role in the pathogenesis of type 1A diabetes. 

Phrase: "Both genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "environmental factors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in the pathogenesis of type 1A diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.9: Since the concordance for type 1A diabetes is only 4050% for monozygotic twins, environmental factors such as toxins, viruses, and certain diets may be involved in the initiation of this disease (4). 

Phrase: "Since"

Phrase: "the concordance for type 1A diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680240:concordance [Social Behavior]

Phrase: "is"

Phrase: "only 4050% for monozygotic twins,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0041432:Monozygotic twins [Family Group]
   760   C0041427:Twins [Family Group]
   760   C0205171:Only [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]
   726 E C0205173:Twin [Functional Concept]

Phrase: "environmental factors such as toxins,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C1516998:Environmental Factors [Functional Concept]
   790 E C0686732:Environmental Factor [Qualitative Concept]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "viruses,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042776:Viruses [Virus]
  1000   C0521026:viruses [Functional Concept]
   966 E C0319157:virus [Virus]

Phrase: "and"

Phrase: "certain diets"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0012155:Diets [Food]
   827 E C1442959:Diet [Organism Function]
   827 E C1519433:DIET [Therapeutic or Preventive Procedure]
   827 E C2983588:DIET [Food]
   777 E C2699635:DIETARY [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "involved in the initiation of this disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0012634:Disease [Disease or Syndrome]
   748   C0589507:Initiation [Mental Process]
   748   C1158830:Initiation [Genetic Function]
   748   C1314939:Involved [Functional Concept]
   748   C1704686:Initiation [Functional Concept]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.10: With the recent increase in the incidence of type 1A diabetes worldwide, many investigators have been searching for environmental factors that could potentially play a role in the pathogenesis of the disease (5). 

Phrase: "With the recent increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in the incidence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0021149:Incidence [Quantitative Concept]
  1000   C0220856:incidence [Functional Concept]
   928 E C1551358:incident [Idea or Concept]

Phrase: "of type 1A diabetes worldwide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1320657:type diabetes [Finding]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]

Phrase: "many investigators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035173:Investigators [Professional or Occupational Group]

Phrase: "have"

Phrase: "been"

Phrase: "searching for environmental factors"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1516998:Environmental Factors [Functional Concept]
   816 E C0686732:Environmental Factor [Qualitative Concept]
   770   C0014406:Environmental [Spatial Concept]
   737   C1521761:Factor [Functional Concept]
   737   C1552603:search [Intellectual Product]
   737   C1706202:Search [Activity]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "could"

Phrase: "potentially"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the pathogenesis of the disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.11: Viruses have been implicated as an important factor triggering type 1A diabetes in genetically susceptible humans and in many animal models (6). 

Phrase: "Viruses"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042776:Viruses [Virus]
  1000   C0521026:viruses [Functional Concept]
   966 E C0319157:virus [Virus]

Phrase: "have"

Phrase: "been"

Phrase: "implicated as an important factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "triggering"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032930:Trigger [Clinical Attribute]
   966   C1444748:Trigger [Qualitative Concept]

Phrase: "type 1A diabetes in genetically susceptible humans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1320657:Diabetes type [Finding]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and in many animal models"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0599779:Models, Animal [Animal]
   760   C0003062:Animal [Animal]
   760   C1515981:And [Idea or Concept]
   760   C3161035:Models [Intellectual Product]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.12: The mechanism of viral infection leading to -cell destruction may be due to its direct or indirect effect on the -cells of the pancreas or directly on lymphoid cells. 

Phrase: "The mechanism of viral infection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "leading"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332152:Leading [Temporal Concept]
  1000   C1522538:Leading [Functional Concept]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to -cell destruction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1261381:Destruction [Therapeutic or Preventive Procedure]
   827   C1948029:Destruction [Activity]

Phrase: "may"

Phrase: "be due to its direct"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0439851:Direct [Qualitative Concept]
   760   C1947931:Direct [Qualitative Concept]
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]

Phrase: "or"

Phrase: "indirect effect on the -cells of the pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "directly on lymphoid cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0086574:Lymphoid Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C1518071:Lymphoid [Qualitative Concept]
   770   C1947931:Directly [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.13: Furthermore, islet -cells produce a wide range of antiviral responses for host protection that may stimulate an immune-mediated islet destruction (7). 

Phrase: "Furthermore,"

Phrase: "islet -cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   966 E C1522529:Islet Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "produce"

Phrase: "a wide range of antiviral responses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "for host protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1545588:Protection [Finding]

Phrase: "that"

Phrase: "may"

Phrase: "stimulate"

Phrase: "an immune-mediated islet destruction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1261381:Destruction [Therapeutic or Preventive Procedure]
   812   C1948029:Destruction [Activity]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.14: There is accumulating evidence implicating the viral induction of the cytokine interferon (IFN)- in the disease process (811). 

Phrase: "There"

Phrase: "is"

Phrase: "accumulating"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "implicating"

Phrase: "the viral induction of the cytokine interferon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "(IFN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "-"

Phrase: "in the disease process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "(811"

Phrase: ")."
Processing 00000000.tx.15: There have been numerous case reports describing IFN- therapy and the appearance of islet autoantibodies, i.e., type 1A diabetes (12). 

Phrase: "There"

Phrase: "have"

Phrase: "been"

Phrase: "numerous case reports"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007320:Case Reports [Intellectual Product]
   867 E C0085973:Case Report [Intellectual Product]
   827   C0684224:Reports [Intellectual Product]
   827   C0700287:reports [Health Care Activity]
   827   C0868928:Case [Functional Concept]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]
   793 E C3273238:Report [Intellectual Product]

Phrase: "describing"

Phrase: "IFN- therapy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0279030:interferon therapy [Therapeutic or Preventive Procedure]
   861   C0039798:therapy [Functional Concept]
   861   C0087111:Therapy [Therapeutic or Preventive Procedure]
   861   C1363945:Therapy [Finding]

Phrase: "and"

Phrase: "the appearance of islet autoantibodies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0233426:Appearance [Organism Attribute]
   760   C0700364:Appearance [Qualitative Concept]

Phrase: "i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "type 1A diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1320657:type diabetes [Finding]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.16: In addition, IFN- can accelerate and induce autoimmune diabetes when expressed as a transgene in islets of mice (13). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "can"

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "and"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "autoimmune diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205734:Diabetes, Autoimmune [Disease or Syndrome]
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "when"

Phrase: "expressed as a transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282641:Transgene [Gene or Genome]

Phrase: "in islets"

Phrase: "of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.17: Double-stranded RNA is produced during the process of viral replication of both DNA and RNA viruses (14). 

Phrase: "Double-stranded RNA"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0035693:RNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   865   C1979882:Double strand [Qualitative Concept]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205173:Double [Functional Concept]
   827   C1705764:Double [Activity]
   827   C1705765:Double [Qualitative Concept]
   755   C1704972:Strand [Spatial Concept]
   755   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "produced during the process of viral replication of both DNA"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0042774:viral replication [Organism Function]
   757   C0012939:DNA, Viral [Nucleic Acid, Nucleoside, or Nucleotide]
   757   C0598312:DNA Replication [Genetic Function]
           Replication
   757   C1514849:Replication Process [Genetic Function]
   757   C2984261:DNA replication [Functional Concept]
   739   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0521026:Viral [Functional Concept]
   739   C1184743:Process [Body Part, Organ, or Organ Component]
   739   C1522240:Process [Phenomenon or Process]
   739   C1883725:replication [Qualitative Concept]

Phrase: "and"

Phrase: "RNA viruses"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0035691:RNA Viruses [Virus]
   861   C0042776:Viruses [Virus]
   861   C0521026:viruses [Functional Concept]
   827 E C0319157:virus [Virus]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.18: The viral mimic poly I:C (polyinosinic:polycytidilic acid) is a synthetic double-stranded RNA that stimulates an immune response similar to those observed in viral infections and is specifically recognized by toll-like receptor 3 (7). 

Phrase: "The viral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521026:Viral [Functional Concept]

Phrase: "mimic"

Phrase: "poly I:C (polyinosinic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   708   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "polycytidilic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "is"

Phrase: "a synthetic double-stranded RNA"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0035693:RNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   825   C1979882:Double strand [Qualitative Concept]
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0205173:Double [Functional Concept]
   812   C1705764:Double [Activity]
   812   C1705765:Double [Qualitative Concept]
   741   C1704972:Strand [Spatial Concept]
   741   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that"

Phrase: "stimulates"

Phrase: "an immune response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0301872:Immune response [Organ or Tissue Function]
   861   C0439662:Immune [Functional Concept]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "observed in viral infections"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0042769:Viral Infections [Disease or Syndrome]
   770   C0009450:Infections [Disease or Syndrome]
   770   C0521026:Viral [Functional Concept]
   770   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "is"

Phrase: "specifically"

Phrase: "recognized by toll-like receptor 3"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C1313494:Toll-Like Receptor 3 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   882   C1336635:TOLL-LIKE RECEPTOR 3 [Gene or Genome]
   882   C1534866:Toll-Like Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   833   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   753   C1336636:TOLL [Gene or Genome]
   753   C1705581:TOLL [Gene or Genome]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.19: Furthermore, poly I:C is a potent IFN- inducer that stimulates a variety of cells of the innate immune system, namely dendritic cells, macrophages, T-cells, and NK cells (7). 

Phrase: "Furthermore,"

Phrase: "poly I:C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "a potent IFN- inducer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0021742:interferon inducer [Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "stimulates"

Phrase: "a variety of cells of the innate immune system,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1883525:Variety [Conceptual Entity]
   742   C2346866:Variety [Conceptual Entity]

Phrase: "namely dendritic cells,"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   901   C0011306:Dendritic Cells [Cell]
   867 E C0003315:Dendritic cell [Cell]
   867 E C1511762:Dendritic Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0011305:Dendritic [Cell Component]
   827   C0439640:Dendritic [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "macrophages,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "T-cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "NK cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0022688:NK Cells [Cell]
           NK
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.20: Poly I:C induces diabetes in the BB rat (15,16) and in streptozotocin-treated mice (13). 

Phrase: "Poly I:C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "diabetes in the BB rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(15,"

Phrase: "16"

Phrase: ")"

Phrase: "and in streptozotocin-treated mice"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C1515981:And [Idea or Concept]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.21: Paradoxically, low-dose poly I:C has been shown to prevent diabetes in NOD mice (17). 

Phrase: "Paradoxically,"

Phrase: "low-dose poly I:C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   853   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   840   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0021966:I- [Inorganic Chemical]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "diabetes in NOD mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.22: In "normal" wild-type BALB/c mice, insulin autoantibodies and insulitis were induced following immunization with insulin peptide B:923 and poly I:C (18). 

Phrase: "In ""normal"" wild-type BALB/c mice,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   851   C1520150:Wild Type Mouse [Mammal]
   845   C0025919:Mice, BALB C [Mammal]
           BALB/C
   845   C0445393:Wild C [Intellectual Product]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "insulin autoantibodies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   966   C1275890:Insulin autoantibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0004358:Autoantibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulitis"

Phrase: "were"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "immunization with insulin peptide B:923"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   753   C0042196:immunisation [Therapeutic or Preventive Procedure]
   753   C3244291:immunization [Functional Concept]

Phrase: "and"

Phrase: "poly I:C (18"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   875   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0021966:I- [Inorganic Chemical]
   812   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0747726:POLY [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.23: Poly I:C has also been shown to induce diabetes in transgenic mice in which -cells express the human costimulatory molecule B7.1 under the control of the rat insulin promoter (RIP) (19). 

Phrase: "Poly I:C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "diabetes in transgenic mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]

Phrase: "in which -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "the human costimulatory molecule B7.1 under the control"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   807   C0104998:B7-1 Costimulatory Molecule [Amino Acid, Peptide, or Protein,Immunologic Factor]
           B7-1
   764   C1366561:B7-1 [Gene or Genome]
   764   C1705431:B7-1 [Gene or Genome]
   764   C2985420:Costimulatory Molecule [Amino Acid, Peptide, or Protein]
   742   C0086418:Human [Human]
   742   C0243148:control [Qualitative Concept]
   742   C0567416:Molecule [Substance]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]

Phrase: "of the rat insulin promoter (RIP)"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.24: We have recently shown that diabetes induction with poly I:C in mice expressing the B7.1 molecule in islet -cells is related to genetic background. 

Phrase: "We"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that diabetes induction with poly I:C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "the B7.1 molecule in islet -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0567416:Molecule [Substance]

Phrase: "is"

Phrase: "related to genetic background."
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C1706907:Background [Conceptual Entity]
   737 E C0163712:Relate [Organic Chemical]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]
Processing 00000000.tx.25: C57BL/6 mice treated with poly I:C develop diabetes, whereas BALB/c mice are resistant (20). 

Phrase: "C57BL/6 mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   988   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   913   C0025921:Mice, C57BL [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "treated with poly I:C"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   862   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   806   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   797   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0021966:I- [Inorganic Chemical]
   760   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0747726:POLY [Conceptual Entity]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "develop"

Phrase: "diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "whereas"

Phrase: "BALB/c mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025919:Mice, BALB C [Mammal]
           BALB/C
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "resistant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332325:Resistant [Functional Concept]
  1000   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.26: In this current study, we provide evidence that the induction of IFN- by poly I:C is essential for the development of autoimmune diabetes in RIP-B7.1 mice, and this disease induction can be blocked by systemic administration of antibodies to IFN-.  

Phrase: "In this current study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the induction of IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by poly I:C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "essential for the development of autoimmune diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205224:Essential [Qualitative Concept]

Phrase: "in RIP-B7.1 mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   709   C1514732:Rat-1 [Cell]

Phrase: "and"

Phrase: "this disease induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205263:Induction [Functional Concept]
   861   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "be"

Phrase: "blocked by systemic administration of antibodies"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   790   C0678812:systemic administration [Therapeutic or Preventive Procedure]
   753   C0001554:Administration [Occupational Activity]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0028778:Blocked [Pathologic Function]
   753   C0205373:Systemic [Functional Concept]
   753   C0332206:Blocked [Functional Concept]
   753   C1533734:Administration [Therapeutic or Preventive Procedure]
   753   C2983591:BLOCKED [Research Activity]
   750   C0282682:antibody block [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "to IFN-."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.27: RESEARCH DESIGN AND METHODS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  C57BL/6.RIP-B7.1 and BALB/c.RIP-B7.1 (backcross 10) transgenic mice were kindly given by L. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086912:methods research [Research Activity]
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "C57BL/6.RIP-B7.1"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   861   C1514732:Rat-1 [Cell]
   818   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C1366561:B7-1 [Gene or Genome]
   818   C1521751:C57BL/6 [Mammal]
   818   C1705431:B7-1 [Gene or Genome]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0025921:C57BL [Mammal]
   795   C0034693:Rat, NOS [Mammal]
   795   C0034721:Rat [Mammal]
   795   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "BALB/c.RIP-B7.1"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   861   C1514732:Rat-1 [Cell]
   818   C0025919:BALB/C [Mammal]
   818   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C1366561:B7-1 [Gene or Genome]
   818   C1705431:B7-1 [Gene or Genome]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0034693:Rat, NOS [Mammal]
   795   C0034721:Rat [Mammal]
   795   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(backcross 10"

Phrase: ")"

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "kindly"

Phrase: "given by L."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1442162:GIVEN [Conceptual Entity]
   790   C1550718:given [Idea or Concept]
   790   C3244317:given [Intellectual Product]
   756 E C1947971:Give [Functional Concept]
Processing 00000000.tx.28: Wen (Yale University). 

Phrase: "Wen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014511:Wen [Anatomical Abnormality]
  1000   C0086809:Wen [Anatomical Abnormality]
  1000   C1547963:Wen [Intellectual Product]

Phrase: "(Yale University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: ")."
Processing 00000000.tx.29: These mice are designated BL/6 B7.1 and BALB/c B7.1, respectively. 

Phrase: "These mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "BL/6 B7.1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1366561:B7-1 [Gene or Genome]
   861   C1705431:B7-1 [Gene or Genome]
   812   C0006413:BL [Neoplastic Process]
   812   C1552663:BL [Idea or Concept]
   812   C2827109:BL [Geographic Area]

Phrase: "and"

Phrase: "BALB/c B7.1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0025919:BALB/C [Mammal]
   861   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1366561:B7-1 [Gene or Genome]
   861   C1705431:B7-1 [Gene or Genome]

Phrase: "respectively."
Processing 00000000.tx.30: Backcross (BC) mice were created by crossing (C57BL/6-RIP-B7.1 x BALB/c) F1 to BALB/c. 

Phrase: "Backcross (BC) mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "created by crossing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1707531:Created By [Qualitative Concept]
   790   C1706214:Created [Activity]
   756 E C3244320:create [Functional Concept]

Phrase: "(C57BL/6-RIP-B7.1 x BALB/c) F1"

Phrase: "to BALB/c."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025919:BALB/C [Mammal]
Processing 00000000.tx.31: The RIP-B7.1 transgene expression was detected by PCR amplification of the B7.1 gene using genomic DNA isolated from tail biopsies. 

Phrase: "The RIP-B7.1 transgene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   877   C1514735:Rat Transgene [Research Activity]
   795   C0185117:Expression [Therapeutic or Preventive Procedure]
   795   C0282641:Transgene [Gene or Genome]

Phrase: "was"

Phrase: "detected by PCR amplification of the B7.1 gene"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   764   C1366561:B7-1 [Gene or Genome]
   764   C1705431:B7-1 [Gene or Genome]
   762   C0017256:Gene Amplification [Genetic Function]
   762   C1705759:Gene Amplification [Cell or Molecular Dysfunction]
           Amplification
   742   C0017337:Gene [Gene or Genome]
   742   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0442726:Detected [Finding]
   742   C0677874:pCR [Finding]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
   742   C1517480:Amplification [Molecular Biology Research Technique]
   742   C1521871:Amplification [Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "isolated from tail biopsies."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0005558:biopsies [Diagnostic Procedure]
   770   C0039259:Tail [Body Part, Organ, or Organ Component]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0220797:biopsy [Functional Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.32: C57BL/6 mice and BALB/c were purchased from The Jackson Laboratory. 

Phrase: "C57BL/6 mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   988   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   913   C0025921:Mice, C57BL [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "BALB/c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025919:BALB/C [Mammal]

Phrase: "were"

Phrase: "purchased from The Jackson Laboratory."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C0869011:purchased [Activity]
   760   C3244292:laboratory [Functional Concept]
Processing 00000000.tx.33: The mice were housed in a pathogen-free animal colony at the Barbara Davis Center for Childhood Diabetes with approved protocols from the University of Colorado Health Sciences Center Animal Care and Use Committee. 

Phrase: "The mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "housed in a pathogen-free animal colony"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C0596092:Animal Colony [Group]
   748   C0003062:Animal [Animal]
   748   C0020056:Housed [Manufactured Object]
   748   C0332296:free [Functional Concept]
   748   C0439158:colony [Quantitative Concept]
   748   C0450254:Pathogen [Organism]
   748   C1880497:Free [Qualitative Concept]
   748   C1947989:Colony [Cell]
   748   C1996904:Free [Qualitative Concept]
   714 E C0442519:house [Conceptual Entity]
   714 E C2003847:House [Manufactured Object]

Phrase: "at the Barbara Davis"

Phrase: "Center for Childhood Diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]
   770   C0205099:Center [Spatial Concept]
   770   C0231335:Childhood [Temporal Concept]

Phrase: "with approved protocols"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C2346846:Approved Protocol [Functional Concept]
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]

Phrase: "from the University of Colorado Health Sciences Center Animal Care"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   850   C0086388:Health Care [Health Care Activity]
   812   C0178478:animal care [Occupation or Discipline]
   793   C1947933:Care [Activity]

Phrase: "and"

Phrase: "Use Committee."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2699414:Committee [Group]
Processing 00000000.tx.34: Reagents. 

Phrase: "Reagents."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.35: Poly I:C salt was purchased from Sigma-Aldrich. 

Phrase: "Poly I:C salt"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0036140:Salt [Chemical Viewed Structurally]
   812   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0206136:Salt [Food,Inorganic Chemical]
   756   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   741 E C1537053:salty [Qualitative Concept]
   712 E C0678584:saltiness [Qualitative Concept]
   708   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "purchased from Sigma-Aldrich."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0869011:purchased [Activity]
   770   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.36: Mouse IFN- was purchased from Research Diagnostics (Flanders, NJ), and rat IgG1 anti-mouse IFN- antibody (clone F18, 6.25 x 104 neutralizing units/mg antibody) was purchased from Cell Sciences (Canton, MA). 

Phrase: "Mouse IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "purchased from Research Diagnostics"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C1511890:Diagnostics Research [Research Activity]
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   770   C0869011:purchased [Activity]
   737   C0011900:Diagnostic [Finding]
   737   C0348026:Diagnostic [Functional Concept]

Phrase: "(Flanders,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1875156:Flanders [Inorganic Chemical,Pharmacologic Substance]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "rat IgG1 anti-mouse IFN- antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   876   C2754944:IgG1 antibody [Cell Component]
   858   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(clone F18,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413834:F18 [Gene or Genome]

Phrase: "6.25 x 104 neutralizing units/mg antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   836   C0475463:Neutralizing Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0487172:Mg Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "purchased from Cell Sciences"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007634:Cell [Cell]
   770   C0036397:Sciences [Occupation or Discipline]
   770   C0869011:purchased [Activity]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "(Canton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707260:Canton [Geographic Area]

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.37: Insulin peptide B:923 (SHLVEALYLVCGERG) and tetanus toxin (TT) peptide 830843 (QYIKANSKFIGIFE) were purchased from SynPep (Dublin, CA). 

Phrase: "Insulin peptide B:923"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0070338:peptide B [Amino Acid, Peptide, or Protein]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(SHLVEALYLVCGERG"

Phrase: ")"

Phrase: "and"

Phrase: "tetanus toxin (TT) peptide 830843"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0039617:Tetanus Toxin [Amino Acid, Peptide, or Protein,Hazardous or Poisonous Substance]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0039614:Tetanus [Disease or Syndrome]
   812   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "(QYIKANSKFIGIFE"

Phrase: ")"

Phrase: "were"

Phrase: "purchased from SynPep"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(Dublin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454777:Dublin [Geographic Area]

Phrase: "CA)."
Processing 00000000.tx.38: The peptide was >90% high-performance liquid chromatography purified, dissolved in lipopolysaccharide-free sterile saline, and adjusted to a neutral pH. 

Phrase: "The peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was >"

Phrase: "90% high-performance liquid chromatography"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   937   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   937   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   937   C1579831:High performance liquid chromatography [Functional Concept]
   840   C0008565:Liquid Chromatography [Laboratory Procedure]
   804   C0008550:Chromatography [Laboratory Procedure]
   804   C0205250:High [Qualitative Concept]
   804   C0302908:Liquid [Substance]
   804   C0597198:Performance [Individual Behavior]
   804   C1299351:High [Qualitative Concept]
   804   C1304698:Liquid [Finding]
   804   C1546699:Liquid NOS [Intellectual Product]
   804   C1561501:Liquid NOS [Substance]
   804   C1882330:Performance [Activity]
   804   C2700149:HIGH [Intellectual Product]
   704 E C0302647:chromatograph [Medical Device]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: ","

Phrase: "dissolved in lipopolysaccharide-free sterile saline,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0023810:Lipopolysaccharide [Lipid]
   753   C0036082:Saline [Substance]
   753   C0232920:Sterile [Qualitative Concept]
   753   C0332296:free [Functional Concept]
   753   C0678108:Sterile [Pathologic Function]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   719   C1549535:Dissolve [Functional Concept]

Phrase: "and"

Phrase: "adjusted to a neutral pH."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1882074:Neutral pH [Qualitative Concept]
           Neutral
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]
   760   C0456081:Adjusted [Functional Concept]
   760   C2825492:Neutral [Phenomenon or Process]
Processing 00000000.tx.39: Disease induction protocol. 

Phrase: "Disease induction protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0442711:Protocol [Intellectual Product]
   827   C1507394:Protocol [Intellectual Product]
   827   C1522729:Protocol [Intellectual Product]
   827   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.40: Poly I:C was given intraperitoneally on days 15 and 814 (starting at 4 weeks of age) at a concentration of 7.5 g/g body wt. 

Phrase: "Poly I:C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "intraperitoneally on days 15"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "814"

Phrase: "(starting at 4 weeks of age)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0439659:Start [Temporal Concept]

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 7.5 g/g body wt."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C2700323:WT [Fish]
Processing 00000000.tx.41: In the group of mice given recombinant mouse IFN-, 10,000 units i.p. were given as per the poly I:C protocol. 

Phrase: "In the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "recombinant mouse IFN-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1522537:Recombinant Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "10,000 units i.p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0021966:I- [Inorganic Chemical]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "were"

Phrase: "given as"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1442162:GIVEN [Conceptual Entity]
   833   C1550718:given [Idea or Concept]
   833   C3244317:given [Intellectual Product]
   799 E C1947971:Give [Functional Concept]

Phrase: "per the poly I:C protocol."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0442711:Protocol [Intellectual Product]
   812   C1507394:Protocol [Intellectual Product]
   812   C1522729:Protocol [Intellectual Product]
   812   C2348563:Protocol [Intellectual Product]
   756   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   708   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.42: In the group of mice given anti-mouse IFN- monoclonal antibody and poly I:C, 60,000 units i.p. of anti-mouse IFN- monoclonal antibody was given three times a week during weeks 3 and 4 and subsequently given 80,000 units i.p. three times a week during weeks 5 and 6. 

Phrase: "In the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "anti-mouse IFN- monoclonal antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   888   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   840   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0746619:monoclonal [Finding]

Phrase: "and"

Phrase: "poly I:C, 60,000 units i.p."

Phrase: "of anti-mouse IFN- monoclonal antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   888   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   840   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0746619:monoclonal [Finding]

Phrase: "was"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "three times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "a week during weeks 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332174:/week [Temporal Concept]
   760   C0439230:week [Temporal Concept]

Phrase: "and"

Phrase: "4"

Phrase: "and"

Phrase: "subsequently"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "80,000 units i.p. three times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   795   C0040223:times [Temporal Concept]
   795   C1632851:Times [Quantitative Concept]
   762 E C3541383:Time [Temporal Concept]
   724 E C0442043:Temporal [Spatial Concept]
   724 E C2362314:Temporal [Temporal Concept]

Phrase: "a week during weeks 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332174:/week [Temporal Concept]
   760   C0439230:week [Temporal Concept]

Phrase: "and"

Phrase: "6."
Processing 00000000.tx.43: This regimen was based on a similar work described by Stewart et al. 

Phrase: "This regimen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040808:Regimen [Therapeutic or Preventive Procedure]
  1000   C2945654:regimen [Intellectual Product]

Phrase: "was"

Phrase: "based on a similar work"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0043227:Work [Occupational Activity]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C2348205:Similar [Qualitative Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "described by Stewart et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1551641:Stewart [Population Group]
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.44: (21). 

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.45: Poly I:C was given intraperitoneally as per protocol described above. 

Phrase: "Poly I:C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "intraperitoneally as"

Phrase: "per protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442711:Protocol [Intellectual Product]
  1000   C1507394:Protocol [Intellectual Product]
  1000   C1522729:Protocol [Intellectual Product]
  1000   C2348563:Protocol [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.46: Blood glucose was measured weekly with the Freestyle blood glucose monitoring system (Therasense, Alameda, CA), and the mice were considered diabetic after two consecutive blood glucose values >250 mg/dl. 

Phrase: "Blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "weekly with the Freestyle blood glucose monitoring system"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   800   C1820407:blood glucose monitoring [Finding]
   770   C0005802:Blood Glucose [Carbohydrate]
   770   C0202048:glucose monitoring [Health Care Activity]
   770   C1139730:monitoring system [Medical Device]
   744   C0005767:Blood [Tissue]
   744   C0005768:blood [Body Substance]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0150369:Monitoring [Health Care Activity]
   744   C0229664:Blood [Body Substance]
   744   C0332174:Weekly [Temporal Concept]
   744   C0449913:System [Functional Concept]
   744   C1516647:monitoring [Research Activity]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]
   739   C0242201:Hemic System [Body System]
   717 E C0489903:Vascular System [Body System]

Phrase: "(Therasense,"

Phrase: "Alameda,"

Phrase: "CA),"

Phrase: "and"

Phrase: "the mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "diabetic after two consecutive blood glucose values"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0241863:DIABETIC [Finding]

Phrase: ">250 mg/dl."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439269:mg dl [Quantitative Concept]
   827   C3642216:/dL [Quantitative Concept]
Processing 00000000.tx.47: IFN- measurement. 

Phrase: "IFN- measurement."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2825783:Interferon Measurement [Laboratory Procedure]
   861   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.48: Mouse IFN- in serum was detected using the enzyme-linked immunosorbent assay kit purchased from PBL Biomedical Laboratories (Piscataway, NJ). 

Phrase: "Mouse IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the enzyme-linked immunosorbent assay kit"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0812225:KIT [Medical Device]
   804   C1150635:KIT [Molecular Function]
   804   C1705212:Kit [Medical Device]
   804   C1705213:KIT [Medical Device]
   804   C3273202:Kit [Manufactured Object]
   771   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   708   C2717977:Enzyme Assay [Laboratory Procedure]

Phrase: "purchased from PBL Biomedical Laboratories"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C0869011:purchased [Activity]
   760   C1518997:PBL [Cell]
   760   C1619828:Laboratories [Intellectual Product]
   760   C1879848:Biomedical [Biomedical Occupation or Discipline]
   726 E C3244292:laboratory [Functional Concept]

Phrase: "(Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")."
Processing 00000000.tx.49: The standard provided by the kit is based on the international standard for mouse IFN- provided by the National Institute of Health. 

Phrase: "The standard"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1442989:Standard [Qualitative Concept]
  1000   C2828392:Standard [Intellectual Product]

Phrase: "provided by the kit"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0812225:KIT [Medical Device]
   770   C1150635:KIT [Molecular Function]
   770   C1705212:Kit [Medical Device]
   770   C1705213:KIT [Medical Device]
   770   C1999230:Provided [Activity]
   770   C3273202:Kit [Manufactured Object]

Phrase: "is"

Phrase: "based on the international standard"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C1442989:Standard [Qualitative Concept]
   760   C1512888:International [Idea or Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C2828392:Standard [Intellectual Product]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "for mouse IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "provided by the National Institute of Health."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0027468:health national institute [Health Care Related Organization]
   748   C0018684:Health [Idea or Concept]
   748   C0021622:institute [Organization]
   748   C1272753:Institute [Idea or Concept]
   748   C1999230:Provided [Activity]
   748   C3245503:national [Intellectual Product]
Processing 00000000.tx.50: The detection range of the assay was 12.5500 pg/ml. 

Phrase: "The detection range of the assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "was"

Phrase: "12.5500 pg/ml."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439297:pg/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.51: This kit does not cross-react with mouse IFN- or -. 

Phrase: "This kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0812225:KIT [Medical Device]
  1000   C1150635:KIT [Molecular Function]
  1000   C1705212:Kit [Medical Device]
  1000   C1705213:KIT [Medical Device]
  1000   C3273202:Kit [Manufactured Object]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cross-react with mouse IFN-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C2828360:Cross [Conceptual Entity]

Phrase: "or -"

Phrase: "."
Processing 00000000.tx.52: IFN- response to poly I:C in vitro. 

Phrase: "IFN- response to poly I:C in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]
Processing 00000000.tx.53: To determine which cell(s) was responsible for the induction of circulating IFN- levels in response to poly I:C in vitro, the following experiment was conducted. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "which cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "s)"

Phrase: "was"

Phrase: "responsible for the induction of circulating IFN- levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to poly I:C in vitro,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0021135:In Vitro [Intellectual Product]
   840   C1533691:in vitro [Qualitative Concept]
           vitro
   840   C2827718:In Vitro [Functional Concept]
   717   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "the following experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "conducted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]
Processing 00000000.tx.54: BC1 B7.1 and BC1 (without B7.1 transgene) mice (four in each group) were killed 4 h postday 6 of poly I:C injections (to mimic the similar peak response seen in serum IFN-, see RESULTS). 

Phrase: "BC1 B7.1"

Phrase: "and"

Phrase: "BC1"

Phrase: "("

Phrase: "without B7.1 transgene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0282641:Transgene [Gene or Genome]
   734   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1366561:B7-1 [Gene or Genome]
   734   C1705431:B7-1 [Gene or Genome]

Phrase: ")"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "(four in each group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205450:Four [Quantitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: ")"

Phrase: "were"

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "4 h postday 6 of poly I:C injections"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   790   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   764   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   762   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   762   C0444953:H 6 [Intellectual Product]
   762   C1424188:I-4 [Gene or Genome]
   762   C1515147:I 4 [Cell]
   762   C1515148:I 6 [Cell]
   742   C0021485:injections [Therapeutic or Preventive Procedure]
   742   C0021966:I- [Inorganic Chemical]
   742   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0033727:H+ [Element, Ion, or Isotope]
   742   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441932:H+ [Classification]
   742   C0564385:/h [Quantitative Concept]
   742   C0747726:POLY [Conceptual Entity]
   742   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   742   C1828121:Injections [Functional Concept]
   708 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "(to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mimic"

Phrase: "the similar peak response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "seen in serum IFN-,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0205397:Seen [Qualitative Concept]
   770   C0229671:Serum [Body Substance]
   770   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: ")."
Processing 00000000.tx.55: A separate group of mice without any in vivo exposure to poly I:C was studied as well. 

Phrase: "A separate group of mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0441835:Group A [Classification]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "without any in vivo exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "to poly I:C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "studied as well."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205170:Well [Qualitative Concept]
   790   C3146287:Well [Manufactured Object]
   756   C0557651:Study [Manufactured Object]
   756   C2603343:Study [Research Activity]
Processing 00000000.tx.56: Splenocytes and lymphocytes from pancreatic lymph nodes were cultured (1 x 108 cells/ml) in a final volume of 200 l in a 96-well flat-bottom microtiter plate in RPMI-1640 with 0.5% (heat-inactivated) mouse serum, 1 mmol/l sodium pyruvate, penicillin-streptomycin, and 1% HEPES. 

Phrase: "Splenocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1519477:Splenocyte [Cell]

Phrase: "and"

Phrase: "lymphocytes from pancreatic lymph nodes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0229892:Lymph lymphocyte [Cell]
   760   C0024264:Lymphocytes [Cell]

Phrase: "were"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "(1 x 108 cells/ml) in a final volume"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C2699156:Cells/mL [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]

Phrase: "of 200 l"

Phrase: "in a 96-well flat-bottom microtiter plate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1709027:Microtiter Plate [Research Device]
   799   C0005971:Plate [Medical Device]
   799   C1139930:plate [Medical Device]
   799   C3537155:Plate [Manufactured Object]

Phrase: "in RPMI-1640"

Phrase: "with 0.5%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "(heat-inactivated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018837:Heat [Natural Phenomenon or Process]

Phrase: ")"

Phrase: "mouse serum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "1 mmol/l sodium pyruvate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1576824:Sodium Pyruvate [Organic Chemical,Pharmacologic Substance]
   804   C0034354:pyruvate [Organic Chemical]
   804   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "penicillin-streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "1% HEPES."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.57: Cells were cultured with no stimulus or with poly I:C at a 100-g/ml final concentration. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured with no stimulus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0234402:Stimulus [Phenomenon or Process]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "or with poly I:C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   806   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   797   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0021966:I- [Inorganic Chemical]
   760   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0747726:POLY [Conceptual Entity]

Phrase: "at a 100-g/ml final concentration."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0086045:Concentration [Mental Process]
   804   C1446561:Concentration [Quantitative Concept]
   733 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.58: At the end of a 24-h culture period, samples of supernatant were obtained for IFN- analysis. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of a 24-h culture period,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0439531:/period [Temporal Concept]
   812   C1948053:Period [Temporal Concept]
   741 E C0332182:Periodic [Temporal Concept]
   741 E C1706381:PERIODIC [Intellectual Product]
   712 E C0031084:Periodicities [Temporal Concept]

Phrase: "samples of supernatant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0370003:Sample [Substance]
   756   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "obtained for IFN- analysis."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0936012:Analysis [Research Activity]
   770   C1301820:Obtained [Functional Concept]
   770   C1524024:analysis [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.59: Pancreatic islets were isolated from the BC1 B7.1 mice by collagenase digestion. 

Phrase: "Pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "isolated from the BC1 B7.1 mice"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   767   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C1366561:B7-1 [Gene or Genome]
   767   C1705431:B7-1 [Gene or Genome]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0205409:Isolated [Functional Concept]
   744   C1548221:Isolated [Idea or Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "by collagenase digestion."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0012238:Digestion [Organism Function]
   861   C2349986:Digestion [Research Activity]
   805 E C0443277:Peptic [Functional Concept]
Processing 00000000.tx.60: Pancreatic islets were dispersed in calcium-free HEPES-buffered Earles medium containing 1 mmol/l EDTA and 25 g/ml trypsin. 

Phrase: "Pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "dispersed in calcium-free HEPES-buffered Earles medium"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   767   C0596235:Free Calcium [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0006726:Calcium [Inorganic Chemical]
   744   C0009458:Medium [Intellectual Product]
   744   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0332296:free [Functional Concept]
   744   C0332624:Dispersed [Spatial Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C1705217:Medium [Substance]
   744   C1880497:Free [Qualitative Concept]
   744   C1996904:Free [Qualitative Concept]
   744   C2936886:Calcium [Pharmacologic Substance]
   744   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 mmol/l EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "25 g/ml trypsin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
Processing 00000000.tx.61: Isolated cells were diluted in the calcium-free Earles medium buffer and filtered through a 63-m nylon screen to remove cell clumps and undigested material. 

Phrase: "Isolated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "diluted in the calcium-free Earles medium buffer"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   767   C0596235:Free Calcium [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0006726:Calcium [Inorganic Chemical]
   744   C0009458:Medium [Intellectual Product]
   744   C0332296:free [Functional Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C1705217:Medium [Substance]
   744   C1880497:Free [Qualitative Concept]
   744   C1996904:Free [Qualitative Concept]
   744   C2936886:Calcium [Pharmacologic Substance]
   744   C3244283:medium [Intellectual Product]
   711   C1720119:Dilute [Functional Concept]
   711   C1948037:Dilute [Functional Concept]

Phrase: "and"

Phrase: "filtered through a 63-m nylon"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C0740034:Nylon [Biomedical or Dental Material]
   719   C0180860:Filter [Manufactured Object]
   719   C0581406:Filter [Medical Device]
   719   C1522664:Filter [Intellectual Product]
   719   C1704449:Filter [Conceptual Entity]
   719   C1704684:Filter [Medical Device]
   719   C1875155:FILTER [Medical Device]

Phrase: "screen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220908:screen [Health Care Activity]
  1000   C1305399:screen [Functional Concept]
  1000   C1705053:Screen [Medical Device]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "cell clumps"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205387:clumps [Qualitative Concept]

Phrase: "and"

Phrase: "undigested material."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]
Processing 00000000.tx.62: Islet cells were seeded at a concentration of 2 x 104 cells/200 l in a 96-well flat-bottom plate with RPMI-1640 medium (Invitrogen) supplemented with 10% heat-activated fetal bovine serum, 1 mmol/l HEPES, 1 mmol/l sodium pyruvate, penicillin-streptomycin, 2 mmol/l L-glutamine, and nonessential amino acids. 

Phrase: "Islet cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   966 E C1522529:Islet Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded at a concentration of 2 x 104 cells/200 l"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   754   C0347983:cells/L [Quantitative Concept]
   738   C0007634:Cells [Cell]
   738   C0086045:Concentration [Mental Process]
   738   C1446561:Concentration [Quantitative Concept]
   738   C3282337:Cells [Cell]
   737 E C0022827:cell l [Cell]
   704   C0036563:Seed [Plant]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704   C1705192:Seed [Laboratory Procedure]
   704   C1882540:{Seed} [Quantitative Concept]
   704 E C1948049:Cell [Spatial Concept]
   704   C2346495:Seed [Conceptual Entity]

Phrase: "in a 96-well flat-bottom plate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0005971:Plate [Medical Device]
   804   C1139930:plate [Medical Device]
   804   C3537155:Plate [Manufactured Object]

Phrase: "with RPMI-1640 medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "supplemented with 10% heat-activated fetal bovine serum,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   744   C0007452:Bovine [Mammal]
   744   C0015965:Fetal [Embryonic Structure]
   744   C0018837:Heat [Natural Phenomenon or Process]
   744   C0229671:Serum [Body Substance]
   744   C0521457:Fetal [Functional Concept]
   744   C1140701:bovine [Mammal]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
   744   C1879547:Activated [Activity]
   711   C0242295:Supplement [Food]
   711 E C1515877:Activate [Functional Concept]
   711   C1947943:Supplement [Intellectual Product]
   711   C2348609:Supplement [Functional Concept]

Phrase: "1 mmol/l HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "1 mmol/l sodium pyruvate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1576824:Sodium Pyruvate [Organic Chemical,Pharmacologic Substance]
   804   C0034354:pyruvate [Organic Chemical]
   804   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "penicillin-streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "2 mmol/l L-glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "nonessential amino acids."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0311461:Non-Essential Amino Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.63: After an overnight incubation (37C, 5% CO2), the islet cells were either activated with or without poly I:C at a 100-g/ml final concentration. 

Phrase: "After an overnight incubation"

Phrase: "(37C,"

Phrase: "5% CO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: ")"

Phrase: ","

Phrase: "the islet cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   966 E C1522529:Islet Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "either"

Phrase: "activated with"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1879547:Activated [Activity]
   799 E C1515877:Activate [Functional Concept]

Phrase: "or without poly I:C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   806   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   797   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0021966:I- [Inorganic Chemical]
   760   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0747726:POLY [Conceptual Entity]

Phrase: "at a 100-g/ml final concentration."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0086045:Concentration [Mental Process]
   804   C1446561:Concentration [Quantitative Concept]
   733 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.64: Supernatant from each well was removed 24 h later for IFN- analysis. 

Phrase: "Supernatant from each well"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "24 h"

Phrase: "later for IFN- analysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0205087:Late [Temporal Concept]
Processing 00000000.tx.65: Immunohistology. 

Phrase: "Immunohistology."
Processing 00000000.tx.66: A portion of the pancreata obtained from the mice was fixed in 10% formalin, paraffin embedded, and stained with hematoxylin and eosin. 

Phrase: "A portion of the pancreata"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449719:Portion [Spatial Concept]

Phrase: "obtained from the mice"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "was"

Phrase: "fixed in 10% formalin,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1550067:10% Formalin [Biomedical or Dental Material,Organic Chemical]
   833   C1561470:10% Formalin [Intellectual Product]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C0949307:Formalin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   770   C2827483:Fixed [Body Substance]

Phrase: "paraffin embedded,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   861   C1707903:Embedded [Laboratory Procedure]

Phrase: "and"

Phrase: "stained with hematoxylin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   841   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "eosin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.67: Pancreatic sections were microscopically examined for the presence of insulitis. 

Phrase: "Pancreatic sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "microscopically"

Phrase: "examined for the presence of insulitis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332128:Examined [Finding]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.68: Paraffin-embedded pancreatic sections were stained with polyclonal guinea pig anti-insulin and anti-glucagon antibodies (Linco Research Immunoassay, St. Charles, MO), followed by a peroxidase-labeled antiguinea pig IgG secondary antibody (Kirkegaard & Perry Laboratories, Gaithersburg, MD). 

Phrase: "Paraffin-embedded pancreatic sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0205155:Section [Spatial Concept]
   779   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   779   C1522472:Section [Substance]
   779   C1552923:Section [Quantitative Concept]
   779   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained with polyclonal guinea pig"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0085979:Guinea pig, NOS [Mammal]
   806   C0999699:Guinea-pig [Mammal]
   760   C0018381:Guinea [Geographic Area]
   760   C1135183:Pig [Mammal]
   760   C1136016:PIG [Mammal]
   760   C1265533:Pig [Mammal]
   760   C1270360:Pig [Mammal]
   760   C2828412:Guinea [Reptile]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "anti-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "anti-glucagon antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Linco Research Immunoassay,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020980:Immunoassay [Laboratory Procedure]
   827   C0021060:immunoassay [Laboratory Procedure]

Phrase: "St. Charles,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "followed by a peroxidase-labeled antiguinea pig IgG secondary antibody"
Meta Candidates (Total=22; Excluded=3; Pruned=0; Remaining=19)
   777   C0598670:peroxidase labeled antibody [Immunologic Factor]
   760   C0332283:Followed by [Temporal Concept]
           followed
   757   C2754943:IgG antibody [Cell Component]
   757   C3272444:PIG-A [Gene or Genome]
   757   C3272445:PIG-A [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0027627:secondary [Neoplastic Process]
   739   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0175668:Secondary [Temporal Concept]
   739   C0205436:Secondary [Quantitative Concept]
   739   C1135183:Pig [Mammal]
   739   C1136016:PIG [Mammal]
   739   C1265533:Pig [Mammal]
   739   C1270360:Pig [Mammal]
   739   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   739   C1708632:Labeled [Qualitative Concept]
   706 E C0181496:Label [Manufactured Object]
   706 E C1719822:Follow [Intellectual Product]
   706 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(Kirkegaard & Perry Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "Gaithersburg,"

Phrase: "MD)."
Processing 00000000.tx.69: Subsequently, the sections were counterstained with hematoxylin and coverslipped. 

Phrase: "Subsequently,"

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "counterstained with hematoxylin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "coverslipped."
Processing 00000000.tx.70: Pancreatic frozen sections were stained by monoclonal antibodies to mouse CD4 and CD8 (Becton Dickinson, San Diego, CA). 

Phrase: "Pancreatic frozen sections"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0016741:Frozen Sections [Tissue]
   867 E C0085188:Frozen Section [Laboratory Procedure]
   827   C0016701:Frozen [Natural Phenomenon or Process]
   827   C0677542:Frozen [Functional Concept]
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained by monoclonal antibodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0746619:monoclonal [Finding]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "to mouse CD4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541261:CD4 [Laboratory Procedure]

Phrase: "and"

Phrase: "CD8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3538720:CD8 [Laboratory Procedure]
  1000   C3540595:CD8 [Gene or Genome]

Phrase: "(Becton Dickinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.71: A universal peroxidase-conjugated secondary antibody (Dako, Glostrop, Denmark) was used as the detection system  RESULTS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Poly I:C triggers diabetes in BL/6 B7.1 but not in BALB/c B7.1 mice. 

Phrase: "A universal peroxidase-conjugated secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Dako,"

Phrase: "Glostrop,"

Phrase: "Denmark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011318:Denmark [Geographic Area]

Phrase: ")"

Phrase: "was"

Phrase: "used as the detection system  RESULTS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   760   C0035171:Research Design [Research Activity]
   757   C0683954:research results [Finding]
   739   C0000857:Abstract [Occupational Activity]
   739   C0035168:research [Research Activity]
   739   C0242481:Research [Research Activity]
   739   C0449913:System [Functional Concept]
   739   C0600678:Abstract [Intellectual Product]
   739   C1273517:used [Finding]
   739   C1511790:Detection [Therapeutic or Preventive Procedure]
   739   C1552863:Abstract [Idea or Concept]
   739   C1553451:System [Manufactured Object]
   739   C1704458:Top [Spatial Concept]
   739   C1704459:System [Medical Device]
   739   C1707689:Design [Activity]
   739   C2983265:DESIGN [Intellectual Product]
   706 E C0042153:use [Functional Concept]
   706 E C0457083:Use [Functional Concept]
   706   C1274040:Result [Functional Concept]
   706   C1546471:Result [Idea or Concept]
   706 E C1947944:Use [Intellectual Product]
   706   C2825142:Result [Finding]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Poly I:C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "diabetes in BL/6 B7.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]

Phrase: "but"

Phrase: "not in BALB/c B7.1 mice."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C0025919:Mice, BALB C [Mammal]
           BALB/C
   778   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C1366561:B7-1 [Gene or Genome]
   778   C1705431:B7-1 [Gene or Genome]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C1518422:Not [Functional Concept]
Processing 00000000.tx.72: We have recently reported that poly I:C, a mimic of viral double-stranded RNA, can induce diabetes in the BL/6 B7.1 model (with islet-induced expression of the costimulatory molecule B7.1), but diabetes induction is decreased when backcrossing the B7.1 transgene onto the BALB/c strain (20). 

Phrase: "We"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that poly I:C,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "a"

Phrase: "mimic of viral double-stranded RNA,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0035693:RNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   783   C0035736:RNA, Viral [Nucleic Acid, Nucleoside, or Nucleotide]
   754   C1979882:Double strand [Qualitative Concept]
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205173:Double [Functional Concept]
   753   C0521026:Viral [Functional Concept]
   753   C1705764:Double [Activity]
   753   C1705765:Double [Qualitative Concept]

Phrase: "can"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "diabetes in the BL/6 B7.1 model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]

Phrase: "("

Phrase: "with islet-induced expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of the costimulatory molecule B7.1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1366561:B7-1 [Gene or Genome]
   861   C1705431:B7-1 [Gene or Genome]
   861   C2985420:Costimulatory Molecule [Amino Acid, Peptide, or Protein]
   812   C0567416:Molecule [Substance]
   741 E C1521991:Molecular [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "diabetes induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205263:Induction [Functional Concept]
   861   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "when"

Phrase: "backcrossing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0524616:Backcrossing [Organism Function]

Phrase: "the B7.1 transgene onto the BALB/c strain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0282641:Transgene [Gene or Genome]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.73: Consistent with prior observations, 78% of the BL/6 B7.1 mice developed diabetes by 20 weeks of age with poly I:C administration (Fig. 1) and 66% of the BC1 B7.1 mice developed diabetes with poly I:C. 

Phrase: "Consistent with prior observations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "78% of the BL/6 B7.1 mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1366561:B7-1 [Gene or Genome]
   770   C1705431:B7-1 [Gene or Genome]
   744   C0006413:BL [Neoplastic Process]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C1552663:BL [Idea or Concept]
   744   C2827109:BL [Geographic Area]

Phrase: "developed"

Phrase: "diabetes by 20 weeks of age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]

Phrase: "with poly I:C administration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001554:Administration [Occupational Activity]
   812   C1533734:Administration [Therapeutic or Preventive Procedure]
   756   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   708   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "66% of the BC1 B7.1 mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C1366561:B7-1 [Gene or Genome]
   767   C1705431:B7-1 [Gene or Genome]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]

Phrase: "developed"

Phrase: "diabetes with poly I:C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.74: Only 10% of the BALB/c B7.1 (backcross 10) became diabetic with poly I:C. 

Phrase: "Only 10% of the BALB/c B7.1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0025919:BALB/C [Mammal]
   770   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1366561:B7-1 [Gene or Genome]
   770   C1705431:B7-1 [Gene or Genome]
   744   C0205171:Only [Quantitative Concept]
   744   C1720467:Only [Intellectual Product]

Phrase: "(backcross 10"

Phrase: ")"

Phrase: "became"

Phrase: "diabetic with poly I:C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0241863:DIABETIC [Finding]
Processing 00000000.tx.75: View larger version (15K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.76: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.77: Life table of diabetes onset in the C57BL/6.RIP-B7.1 (BL/6 B7.1), BALB/c.RIP-B7.1 (BALB/c B7.1), and [(C57BL/6.RIP-B7.1) x BALB/c] F1 x BALB/c for backcross one (BC1 B7.1) mice given poly I:C for 10 days at 4 weeks of age. 

Phrase: "Life table of diabetes onset"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0023683:Life Table [Intellectual Product,Quantitative Concept]
   760   C0039224:Table [Manufactured Object]
   760   C0376558:Life [Idea or Concept]
   760   C1706073:Table [Medical Device]
   760   C1706074:Table [Intellectual Product]

Phrase: "in the C57BL/6.RIP-B7.1"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   861   C1514732:Rat-1 [Cell]
   818   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C1366561:B7-1 [Gene or Genome]
   818   C1521751:C57BL/6 [Mammal]
   818   C1705431:B7-1 [Gene or Genome]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0025921:C57BL [Mammal]
   795   C0034693:Rat, NOS [Mammal]
   795   C0034721:Rat [Mammal]
   795   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(BL/6 B7.1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1366561:B7-1 [Gene or Genome]
   861   C1705431:B7-1 [Gene or Genome]
   812   C0006413:BL [Neoplastic Process]
   812   C1552663:BL [Idea or Concept]
   812   C2827109:BL [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "BALB/c.RIP-B7.1"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   861   C1514732:Rat-1 [Cell]
   818   C0025919:BALB/C [Mammal]
   818   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C1366561:B7-1 [Gene or Genome]
   818   C1705431:B7-1 [Gene or Genome]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0034693:Rat, NOS [Mammal]
   795   C0034721:Rat [Mammal]
   795   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(BALB/c B7.1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0025919:BALB/C [Mammal]
   861   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1366561:B7-1 [Gene or Genome]
   861   C1705431:B7-1 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and [("

Phrase: "C57BL/6.RIP-B7.1"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   861   C1514732:Rat-1 [Cell]
   818   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C1366561:B7-1 [Gene or Genome]
   818   C1521751:C57BL/6 [Mammal]
   818   C1705431:B7-1 [Gene or Genome]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0025921:C57BL [Mammal]
   795   C0034693:Rat, NOS [Mammal]
   795   C0034721:Rat [Mammal]
   795   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "x BALB/c] F1 x BALB/c"

Phrase: "for backcross one (BC1 B7.1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0205447:One [Quantitative Concept]

Phrase: ")"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "poly I:C for 10 days"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   790   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   783   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "at 4 weeks"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442465:4 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.78: - -- -, BL/6 B7.1 (n = 10); 

Phrase: "-"

Phrase: "-"

Phrase: "- -"

Phrase: ","

Phrase: "BL/6 B7.1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1366561:B7-1 [Gene or Genome]
   861   C1705431:B7-1 [Gene or Genome]
   812   C0006413:BL [Neoplastic Process]
   812   C1552663:BL [Idea or Concept]
   812   C2827109:BL [Geographic Area]

Phrase: "(n = 10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.79: , BC 1 (n = 50); 

Phrase: ", BC 1"

Phrase: "(n = 50"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.80: , BALB/c B7.1 (n = 10).  

Phrase: ", BALB/c B7.1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0025919:BALB/C [Mammal]
   861   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1366561:B7-1 [Gene or Genome]
   861   C1705431:B7-1 [Gene or Genome]

Phrase: "(n = 10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.81: C57BL/6 (0/10), BC1 (0/8), and BALB/c (0/8) mice that did not express the B7.1 transgene remained diabetes free with poly I:C when followed up to 40 weeks of age (data not shown). 

Phrase: "C57BL/6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521751:C57BL/6 [Mammal]
   861   C0025921:C57BL [Mammal]

Phrase: "(0/10"

Phrase: ")"

Phrase: ","

Phrase: "BC1"

Phrase: "(0/8"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "BALB/c (0/8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025919:BALB/C [Mammal]

Phrase: ")"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "express"

Phrase: "the B7.1 transgene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0282641:Transgene [Gene or Genome]
   734   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1366561:B7-1 [Gene or Genome]
   734   C1705431:B7-1 [Gene or Genome]

Phrase: "remained"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "free with poly I:C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332296:free [Functional Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]

Phrase: "when"

Phrase: "followed up to 40 weeks of age (data"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   754   C0589120:Follow-up [Finding]
   754   C1522577:follow-up [Health Care Activity]
   754   C1704685:FOLLOW-UP [Intellectual Product]
   754   C3274571:FOLLOW-UP [Health Care Activity]
   744   C0001779:Age [Organism Attribute]
   744   C0332283:followed [Temporal Concept]
   744   C0439230:weeks [Temporal Concept]
   744   C0439509:/40 [Temporal Concept]
   744   C1511726:Data [Idea or Concept]
   744   C3245479:data [Medical Device]
   711 E C0332174:/week [Temporal Concept]
   711 E C1719822:Follow [Intellectual Product]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.82: Peak IFN- after poly I:C stimulation is higher in BL/6 B7.1 mice. 

Phrase: "Peak IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "after"

Phrase: "poly I:C stimulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   812   C1948023:Stimulation [Natural Phenomenon or Process]
   756   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   708   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "higher in BL/6 B7.1 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.83: To investigate the differential effects of poly I:C on the induction of diabetes in the various models, we studied the pattern of IFN- expression in the serum of these mice after poly I:C administration at 4 weeks of age. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the differential effects of poly I:C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on the induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "in the various models,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the pattern of IFN- expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "in the serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "of these mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "after poly I:C administration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001554:Administration [Occupational Activity]
   812   C1533734:Administration [Therapeutic or Preventive Procedure]
   756   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   708   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "at 4 weeks"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442465:4 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.84: We measured IFN- over time following the 6th day of poly I:C administration. 

Phrase: "We"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "over time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the 6th day of poly I:C administration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0332173:/day [Temporal Concept]
   744   C0439228:day [Temporal Concept]
   744   C0439505:/day [Temporal Concept]
Processing 00000000.tx.85: Of note, the IFN- response after the first injection (day 1) of poly I:C in the BC1 B7.1 mice, did not demonstrate any detectable IFN- levels when it was measured at similar times (data not shown). 

Phrase: "Of note,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the IFN- response after the first injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "(day 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: "of poly I:C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "in the BC1 B7.1 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "demonstrate"

Phrase: "any detectable IFN- levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "when"

Phrase: "it"

Phrase: "was"

Phrase: "measured at similar times"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0040223:times [Temporal Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1632851:Times [Quantitative Concept]
   770   C2348205:Similar [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.86: On the 6th day of treatment, serum was taken before the injection of poly I:C (the basal level) and at 1, 2, 4, 6, and 12 h postadministration. 

Phrase: "On the 6th day"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "of treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "was"

Phrase: "taken before the injection of poly I:C ("
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   800   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   770   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   767   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0021485:injection [Therapeutic or Preventive Procedure]
   744   C0021966:I- [Inorganic Chemical]
   744   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0747726:POLY [Conceptual Entity]
   744   C1272883:Injection [Biomedical or Dental Material]
   744   C1533685:Injection [Therapeutic or Preventive Procedure]
   744   C1828121:Injection [Functional Concept]
   744   C1883727:Taken [Conceptual Entity]
   711 E C1515187:Take [Health Care Activity]

Phrase: "the basal level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "at 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4,"

Phrase: "6,"

Phrase: "and"

Phrase: "12 h postadministration."
Processing 00000000.tx.87: IFN- levels appeared to peak earlier in BL/6 B7.1 mice (2 h postinjection) than in BC1 B7.1 and BALB/c B7.1 mice (46 h postinjection). 

Phrase: "IFN- levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "appeared to peak"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444505:Peak [Quantitative Concept]
   756   C0700364:APPEAR [Qualitative Concept]

Phrase: "earlier in BL/6 B7.1 mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1279919:Early [Temporal Concept]

Phrase: "(2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "postinjection"

Phrase: ")"

Phrase: "than"

Phrase: "in BC1 B7.1"

Phrase: "and"

Phrase: "BALB/c B7.1 mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   911   C0025919:Mice, BALB C [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "(46 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "postinjection"

Phrase: ")."
Processing 00000000.tx.88: The backcross 1 (BC1), BALB/c, and C57BL/6 mice without the B7.1 transgene (five mice in each group) have a much lower peak IFN- response compared with the similar group of mice with the B7.1 transgene (P < 0.01) (Fig. 2A). 

Phrase: "The backcross 1 (BC1),"

Phrase: "BALB/c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025919:BALB/C [Mammal]

Phrase: "and"

Phrase: "C57BL/6 mice without the B7.1 transgene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   789   C1521751:C57BL/6 Mouse [Mammal]
   767   C0025921:Mice, C57BL [Mammal]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]

Phrase: "(five mice in each group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]

Phrase: ")"

Phrase: "have"

Phrase: "a much"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "peak IFN- response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "compared with the similar group of mice"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
   748   C1707455:Compared [Activity]
   748   C2348205:Similar [Qualitative Concept]

Phrase: "with the B7.1 transgene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0282641:Transgene [Gene or Genome]
   734   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1366561:B7-1 [Gene or Genome]
   734   C1705431:B7-1 [Gene or Genome]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.89: The mean peak IFN- levels in the BL/6 B7.1 mice was significantly higher than in the BC1 B7.1 and BALB/c B7.1 (P < 0.01) mice. 

Phrase: "The mean peak IFN- levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   858   C0444505:Peak level [Quantitative Concept]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the BL/6 B7.1 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "significantly higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "in the BC1 B7.1"

Phrase: "and"

Phrase: "BALB/c B7.1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0025919:BALB/C [Mammal]
   861   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1366561:B7-1 [Gene or Genome]
   861   C1705431:B7-1 [Gene or Genome]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.90: However, despite a difference in susceptibility to diabetes between BC1 B7.1 and BALB/c B7.1 mice, there was no significant difference in peak IFN- levels, suggesting inherent factors other than IFN- susceptibility that might predispose to diabetes (Fig. 2B). 

Phrase: "However,"

Phrase: "despite a difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "in susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0012655:Susceptibility [Clinical Attribute]
  1000   C0220898:Susceptibility [Organism Attribute]
  1000   C1264642:Susceptibility [Functional Concept]
  1000   C1547045:*Susceptibility [Quantitative Concept]
   928 E C0231204:Susceptible [Functional Concept]
   928 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "between BC1 B7.1"

Phrase: "and"

Phrase: "BALB/c B7.1 mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   911   C0025919:Mice, BALB C [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "there"

Phrase: "was"

Phrase: "no significant difference in peak IFN- levels,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "inherent factors other than IFN- susceptibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "might"

Phrase: "predispose to diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.91: View larger version (24K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.92: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.93: A: Time-course study of peak serum IFN- levels (pg/ml) after poly I:C in C57BL/6, BALB/c, and BC1(x BALB/c) mice with (left panels) and without (right panels) RIP-B7.1 transgene. 

Phrase: "A"

Phrase: ":"

Phrase: "Time-course study of peak serum IFN- levels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0036745:Study of serum [Biomedical Occupation or Discipline]
   767   C0040227:Time Study [Intellectual Product]
   767   C2349982:Study Time [Temporal Concept]
   744   C0557651:Study [Manufactured Object]
   744   C2603343:Study [Research Activity]

Phrase: "(pg/ml) after poly I:C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439297:pg/mL [Quantitative Concept]
   783   C0268226:ML I [Disease or Syndrome]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "in C57BL/6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521751:C57BL/6 [Mammal]
   861   C0025921:C57BL [Mammal]

Phrase: "BALB/c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025919:BALB/C [Mammal]

Phrase: "and"

Phrase: "BC1"

Phrase: "(x BALB/c) mice with"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0025919:Mice, BALB C [Mammal]
           BALB/C
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]

Phrase: "(left panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and without"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "(right panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "RIP-B7.1 transgene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   895   C1514735:Rat Transgene [Research Activity]
   799   C0282641:Transgene [Gene or Genome]
   709   C1514732:Rat-1 [Cell]
Processing 00000000.tx.94: Serum IFN- was measured on day 6 of poly I:C injections. 

Phrase: "Serum IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "measured on day 6 of poly I:C injections."
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   790   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   764   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   762   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   762   C1515148:I 6 [Cell]
   742   C0021485:injections [Therapeutic or Preventive Procedure]
   742   C0021966:I- [Inorganic Chemical]
   742   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0332173:/day [Temporal Concept]
   742   C0439228:day [Temporal Concept]
   742   C0439505:/day [Temporal Concept]
   742   C0444706:Measured [Qualitative Concept]
   742   C0747726:POLY [Conceptual Entity]
   742   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   742   C1828121:Injections [Functional Concept]
   742   C3541902:MEASURED [Diagnostic Procedure]
   708 E C0079809:Measure [Quantitative Concept]
   708 E C0242485:Measure [Functional Concept]
   708 E C1272883:Injection [Biomedical or Dental Material]
Processing 00000000.tx.95: B: Comparison of peak IFN- postpoly I:C in the presence or absence of B7.1 transgene. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Comparison of peak IFN- postpoly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "I:C in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "absence of B7.1 transgene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.96: Horizontal lines represent mean IFN- values.  

Phrase: "Horizontal lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "mean IFN- values."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.97: Lymphoid cells (from spleen) induce higher IFN- than islets in BC1 B7.1 mice. 

Phrase: "Lymphoid cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0086574:Lymphoid Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C1518071:Lymphoid [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "from spleen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037993:Spleen [Body Part, Organ, or Organ Component]
  1000   C0771377:SPLEEN [Tissue]
  1000   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "higher IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "than islets"

Phrase: "in BC1 B7.1 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.98: The mean IFN- production from four BC1 B7.1 mouse splenocytes stimulated in vivo with poly I:C and subsequently in vitro was 68.6 pmol/l. 

Phrase: "The mean IFN- production from four BC1 B7.1 mouse splenocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C3159140:interferon production [Organism Function]
   736   C0033268:production [Occupational Activity]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "in vivo with poly I:C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "subsequently in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]

Phrase: "was"

Phrase: "68.6 pmol/l."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439284:pmol/L [Quantitative Concept]
Processing 00000000.tx.99: This was higher (P < 0.05) when compared with the mean production from lymphocytes (pancreatic lymph nodes) or islets (44.3 and 19.4 pg/ml, respectively) (Table 1). 

Phrase: "This"

Phrase: "was"

Phrase: "higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "when"

Phrase: "compared with the mean production"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0033268:production [Occupational Activity]
   760   C0444504:Mean [Quantitative Concept]
   760   C1707455:Compared [Activity]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]

Phrase: "from lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024264:Lymphocytes [Cell]

Phrase: "(pancreatic lymph nodes"
Meta Candidates (Total=15; Excluded=9; Pruned=0; Remaining=6)
  1000   C0229783:Pancreatic lymph nodes [Body Part, Organ, or Organ Component]
           Pancreatic nodes
   966 E C1280901:Pancreatic lymph node [Body Part, Organ, or Organ Component]
   901   C0024204:lymph nodes [Body Part, Organ, or Organ Component]
   867 E C0440747:LYMPH NODE [Tissue]
   867 E C1269047:Lymph node [Body Part, Organ, or Organ Component]
   827   C0024202:Lymph [Body Substance]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0746922:nodes [Body Part, Organ, or Organ Component]
   793 E C1706163:Node [Conceptual Entity]
   793 E C2697524:Node [Conceptual Entity]
   793 E C2700445:Node [Plant]
   743 E C0443268:Nodal [Spatial Concept]
   743 E C1417752:NODAL [Gene or Genome]
   721 E C0449725:Nodality [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "islets"

Phrase: "(44.3"

Phrase: "and"

Phrase: "19.4 pg/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439297:pg/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.100: In contrast, cells that were not stimulated in vivo had a much lower mean IFN- induction with in vitro poly I:C stimulation alone (spleen 28.6, lymphocytes 19.9, and islets <12.5 pg/ml). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "had"

Phrase: "a much lower mean IFN- induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0205263:Induction [Functional Concept]
   804   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "with in vitro poly I:C stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   799   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(spleen 28.6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037993:Spleen [Body Part, Organ, or Organ Component]
   827   C0771377:SPLEEN [Tissue]
   827   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "lymphocytes 19.9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024264:Lymphocytes [Cell]

Phrase: "and"

Phrase: "islets"

Phrase: "<12.5 pg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439297:pg/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.101: In BC1 B7.1 mice that were given poly I:C in vivo but not in vitro, splenocytes, lymphocytes, and islet induction of IFN- were (mean) 17.8, <12.5, and <12.5 pg/ml, respectively. 

Phrase: "In BC1 B7.1 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "were"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "poly I:C in vivo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1515655:In Vivo [Spatial Concept]
           vivo
   717   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "but"

Phrase: "not in vitro, splenocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1519477:Splenocyte [Cell]

Phrase: "lymphocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024264:Lymphocytes [Cell]

Phrase: "and"

Phrase: "islet induction of IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "(mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: ")"

Phrase: "17.8,"

Phrase: "<12.5,"

Phrase: "and <"

Phrase: "12.5 pg/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439297:pg/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "respectively."
Processing 00000000.tx.102: In BC1 mice without the B7.1 transgene, only splenocytes stimulated in vivo and in vitro induced any detectable IFN- (14.4 pg/ml). 

Phrase: "In BC1 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "without the B7.1 transgene,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0282641:Transgene [Gene or Genome]
   734   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1366561:B7-1 [Gene or Genome]
   734   C1705431:B7-1 [Gene or Genome]

Phrase: "only splenocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519477:Splenocyte [Cell]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro induced"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]
   827   C0205263:Induced [Functional Concept]

Phrase: "any detectable IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(14.4 pg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439297:pg/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.103: Of note, all four mice in each group had detectable IFN-, except the B7.1-negative group of splenocytes given poly I:C in vivo and in vitro (mean 14.4 pg/ml), in which two of the four mice had detectable levels. 

Phrase: "Of note,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "all four mice in each group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "detectable IFN-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "except the B7.1-negative group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "of splenocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1519477:Splenocyte [Cell]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "poly I:C in vivo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1515655:In Vivo [Spatial Concept]
           vivo
   717   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "and"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(mean 14.4 pg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0439297:pg/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "in which two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "of the four mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "detectable levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.104: View this table: [in this window] [in a new window]  TABLE 1 IFN- response after 6 days of in vivo poly I:C stimulation assessing the ability of splenocytes, lymphocytes, and islet cells in culture responding to in vitro and/or in vivo stimulation with poly I:C in BC1- and B7.1-positive and BC1- and B7.1-negative mice  Peak IFN- after poly I:C stimulation is higher in diabetic mice and correlates to age of onset of diabetes. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 IFN- response after 6 days"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]
   738   C1548114:Tabular response [Idea or Concept]

Phrase: "of in vivo poly I:C stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   799   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "assessing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516048:Assess [Activity]

Phrase: "the ability of splenocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "lymphocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024264:Lymphocytes [Cell]

Phrase: "and"

Phrase: "islet cells in culture"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   819   C0007585:cells culture [Laboratory Procedure]
   799 E C1522529:Islet Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "responding to in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0021135:In Vitro [Intellectual Product]
   833   C1533691:in vitro [Qualitative Concept]
           vitro
   833   C2827718:In Vitro [Functional Concept]

Phrase: "and/or"

Phrase: "in vivo stimulation with poly I:C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in BC1-"

Phrase: "and"

Phrase: "B7.1-positive"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]
   734   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1366561:B7-1 [Gene or Genome]
   734   C1705431:B7-1 [Gene or Genome]

Phrase: "and"

Phrase: "BC1-"

Phrase: "and"

Phrase: "B7.1-negative mice  Peak IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   799   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "after"

Phrase: "poly I:C stimulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   812   C1948023:Stimulation [Natural Phenomenon or Process]
   756   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   708   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "higher in diabetic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "correlates to age of onset of diabetes."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   748   C0001779:Age [Organism Attribute]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0332162:Onset [Qualitative Concept]
Processing 00000000.tx.105: A total of 50 BC1 B7.1 mice were divided according to phenotype as diabetes or no diabetes by 40 weeks of age, and the peak IFN- levels were compared for these two groups (Fig. 3). 

Phrase: "A total of 50 BC1 B7.1 mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0439175:% total [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]

Phrase: "were"

Phrase: "divided according to phenotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031437:Phenotype [Organism Attribute]
   770   C0332849:Divided [Functional Concept]
   770   C0680240:according [Social Behavior]
   770   C1285572:Phenotype [Laboratory Procedure]

Phrase: "as diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "or"

Phrase: "no diabetes by 40 weeks of age,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "the peak IFN- levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   896   C0444505:Peak level [Quantitative Concept]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "compared for these two groups"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0205448:Two [Quantitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C1707455:Compared [Activity]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.106: The mean peak IFN- levels were significantly (P < 0.001) higher in the group that progressed to diabetes compared with the nondiabetic group. 

Phrase: "The mean peak IFN- levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   858   C0444505:Peak level [Quantitative Concept]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly"

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "higher in the group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "that"

Phrase: "progressed to diabetes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C1272688:progressed [Functional Concept]
   756 E C1280477:Progress [Functional Concept]

Phrase: "compared with the nondiabetic group."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.107: BC1 B7.1 mice were divided into "high" IFN- responders (rise in IFN- 25 pg/ml from the basal level) and "low" IFN- responders (rise of <25 pg/ml from basal level), and diabetes incidence was compared (Fig. 4). 

Phrase: "BC1 B7.1 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "divided into ""high"" IFN- responders"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0205250:High [Qualitative Concept]
   760   C0332849:Divided [Functional Concept]
   760   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "(rise in IFN- 25 pg/ml"

Phrase: "from the basal level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: "and """

Phrase: "low"" IFN- responders"

Phrase: "(rise of <25 pg/ml from basal level"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439297:pg/mL [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "diabetes incidence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0021149:Incidence [Quantitative Concept]
   861   C0220856:incidence [Functional Concept]
   789 E C1551358:incident [Idea or Concept]

Phrase: "was"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.108: By life-table analysis, an IFN- response of >25 pg/ml is highly predictive of diabetes development (positive predictive value 82%). 

Phrase: "By life-table analysis,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0023679:Life Table Analysis [Occupational Activity]
   901   C0023683:Life Table [Intellectual Product,Quantitative Concept]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0039224:Table [Manufactured Object]
   827   C0376558:Life [Idea or Concept]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1706073:Table [Medical Device]
   827   C1706074:Table [Intellectual Product]
   743 E C0595998:lives [Finding]

Phrase: "an IFN- response of >25 pg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439297:pg/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: "is"

Phrase: "highly predictive of diabetes development"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0681890:predictive [Qualitative Concept]

Phrase: "(positive predictive value 82%"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C1514243:positive predictive value [Quantitative Concept]
   861   C1514307:Predictive Value [Qualitative Concept]
   812   C0439178:% Positive [Quantitative Concept]
   812   C0681890:predictive [Qualitative Concept]
   812   C1446409:Positive [Qualitative Concept]
   812   C1514241:Positive [Finding]
   812   C1522609:Value [Quantitative Concept]
   812   C2825490:Positive [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.109: Finally, the peak IFN- levels were compared with the time to onset (age) of diabetes in the poly I:Ctreated BC1 B7.1 mice. 

Phrase: "Finally,"

Phrase: "the peak IFN- levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   896   C0444505:Peak level [Quantitative Concept]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "compared with the time"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0040223:Time [Temporal Concept]
   770   C1707455:Compared [Activity]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "to onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "(age) of diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001779:Age [Organism Attribute]

Phrase: "in the poly I:Ctreated BC1 B7.1 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0025914:Mice [Mammal]
   793   C0025929:mice [Mammal]
   793   C0026809:Mice [Mammal]
Processing 00000000.tx.110: There was a significant inverse correlation (r = 0.58, P < 0.01) between the age of onset of diabetes with the peak IFN- levels (Fig. 5). 

Phrase: "There"

Phrase: "was"

Phrase: "a significant inverse correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707520:Correlation [Qualitative Concept]

Phrase: "(r = 0.58,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "between the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "with the peak IFN- levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   896   C0444505:Peak level [Quantitative Concept]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.111: These data taken together suggest that the mechanism of diabetes induction with poly I:C in the B7.1 model may involve IFN-. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the mechanism of diabetes induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "with poly I:C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "in the B7.1 model"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C3161035:Model [Intellectual Product]
   734   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1366561:B7-1 [Gene or Genome]
   734   C1705431:B7-1 [Gene or Genome]

Phrase: "may"

Phrase: "involve"

Phrase: "IFN-."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.112: View larger version (14K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.113: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.114: The IFN- peak response postpoly I:C stimulation in BC1 B7.1 diabetic and nondiabetic mice. 

Phrase: "The IFN- peak response postpoly I:C stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   795   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in BC1 B7.1 diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "nondiabetic mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.115: Horizontal lines represent mean IFN- values.  

Phrase: "Horizontal lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "mean IFN- values."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.116: View larger version (15K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.117: 4. 

Phrase: "4."
Processing 00000000.tx.118: The diabetes survival curve in the BC1 (x BALB/c) B7.1 mice given poly I:C according to the change () in serum IFN- from baseline to peak levels. 

Phrase: "The diabetes survival curve in the BC1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0038952:Survival [Activity]
   744   C0205134:Curve [Spatial Concept]
   744   C0220921:survival [Functional Concept]

Phrase: "(x BALB/c) B7.1 mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   885   C0025919:Mice, BALB C [Mammal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "poly I:C according to the change"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   778   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   774   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0021966:I- [Inorganic Chemical]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "("

Phrase: ")"

Phrase: "in serum IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "from baseline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0168634:baseline [Biomedical or Dental Material]
  1000   C1442488:Baseline [Quantitative Concept]

Phrase: "to peak levels."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C0444505:Peak level [Quantitative Concept]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.119: Mice with IFN- levels 25 pg/ml ( [n = 38]) and <25 pg/ml ( [n = 12]) are shown. 

Phrase: "Mice with IFN- levels 25 pg/ml ( [n = 38"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]

Phrase: "]"

Phrase: ")"

Phrase: "and <"

Phrase: "25 pg/ml ( [n = 12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0439297:pg/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]
   804   C1266240:PG [Laboratory Procedure]

Phrase: "]"

Phrase: ")"

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.120: P = 0.0004.  

Phrase: "P = 0.0004."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.121: View larger version (11K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(11K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.122: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.123: The correlation of peak IFN- response on day 6 after poly I:C stimulation and age of onset diabetes in BC1 (x BALB/c) B7.1 mice.  

Phrase: "The correlation of peak IFN- response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707520:Correlation [Qualitative Concept]

Phrase: "on day 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "after poly I:C stimulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   812   C1948023:Stimulation [Natural Phenomenon or Process]
   756   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   708   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "age of onset diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   770   C0001779:Age [Organism Attribute]

Phrase: "in BC1"

Phrase: "(x BALB/c) B7.1 mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   885   C0025919:Mice, BALB C [Mammal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
Processing 00000000.tx.124: Neutralizing IFN- after poly I:C induction prevents diabetes in BL/6 B7.1 and BC1 B7.1 mice. 

Phrase: "Neutralizing IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "after"

Phrase: "poly I:C induction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205263:Induction [Functional Concept]
   812   C0857127:induction [Therapeutic or Preventive Procedure]
   756   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   708   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "diabetes in BL/6 B7.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "BC1 B7.1 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.125: Administration of a monoclonal antibody to IFN- prevented diabetes in all BL/6 B7.1 mice treated with poly I:C (Fig. 6). 

Phrase: "Administration of a monoclonal antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001554:Administration [Occupational Activity]
   760   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "to IFN- prevented diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]

Phrase: "in all BL/6 B7.1 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "treated with poly I:C (Fig. 6"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   814   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   778   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   774   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   774   C1515148:I 6 [Cell]
   748   C0021966:I- [Inorganic Chemical]
   748   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0349966:Fig [Food]
   748   C0747726:POLY [Conceptual Entity]
   748   C1337208:FIG [Food]
   748   C1522326:Treated [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]

Phrase: ")."
Processing 00000000.tx.126: A similar effect was observed in the BC1 B7.1 mice, whereby only 1 of 12 mice developed diabetes when the monoclonal antibody was coadministered with poly I:C. 

Phrase: "A similar effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "observed in the BC1 B7.1 mice,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C1366561:B7-1 [Gene or Genome]
   767   C1705431:B7-1 [Gene or Genome]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C1441672:Observed [Functional Concept]

Phrase: "whereby only 1 of 12 mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0205171:Only [Quantitative Concept]
   753   C1720467:Only [Intellectual Product]

Phrase: "developed"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "when"

Phrase: "the monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "was"

Phrase: "coadministered with poly I:C."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   806   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   797   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0021966:I- [Inorganic Chemical]
   760   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0747726:POLY [Conceptual Entity]
Processing 00000000.tx.127: View larger version (15K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.128: 6. 

Phrase: "6."
Processing 00000000.tx.129: Diabetes survival curve in the in C57BL/6 B7.1 and BC1(x BALB/c) B7.1 mice simultaneously given monoclonal antibody to mouse IFN- and 10 days of poly I:C. 

Phrase: "Diabetes survival curve in the in C57BL/6 B7.1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0038952:Survival [Activity]
   739   C0205134:Curve [Spatial Concept]
   739   C0220921:survival [Functional Concept]

Phrase: "and"

Phrase: "BC1"

Phrase: "(x BALB/c) B7.1 mice simultaneously given monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   822   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C0746619:monoclonal [Finding]

Phrase: "to mouse IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "10 days of poly I:C."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1547061:10 days [Temporal Concept]
   753   C0439228:days [Temporal Concept]
   719 E C0332173:/day [Temporal Concept]
   719 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.130: - -- -, BL/6 + pIC + mAb (n = 10); 

Phrase: "-"

Phrase: "-"

Phrase: "- -"

Phrase: ","

Phrase: "BL/6 + pIC + mAb (n = 10"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0006413:BL [Neoplastic Process]
   799   C0014878:Pike [Fish]
   799   C0522667:Pike [Manufactured Object]
   799   C0730321:PIC [Disease or Syndrome]
   799   C1552663:BL [Idea or Concept]
   799   C2827109:BL [Geographic Area]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.131: , BL/6 + pIC (n = 10); 

Phrase: ", BL/6 + pIC (n = 10"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0006413:BL [Neoplastic Process]
   804   C0014878:Pike [Fish]
   804   C0522667:Pike [Manufactured Object]
   804   C0730321:PIC [Disease or Syndrome]
   804   C1552663:BL [Idea or Concept]
   804   C2827109:BL [Geographic Area]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.132: , BC1 + pIC (n = 50); 

Phrase: ", BC1 + pIC (n = 50"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0014878:Pike [Fish]
   804   C0522667:Pike [Manufactured Object]
   804   C0730321:PIC [Disease or Syndrome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.133: , BC1 + pIC + mAb (n = 12).  

Phrase: ", BC1 + pIC + mAb (n = 12"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0014878:Pike [Fish]
   799   C0522667:Pike [Manufactured Object]
   799   C0730321:PIC [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.134: Recombinant mouse IFN- induces diabetes in BC1 B7.1 mice. 

Phrase: "Recombinant mouse IFN-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1522537:Recombinant Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "diabetes in BC1 B7.1 mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.135: To further support the role of IFN- in the induction of diabetes in this B7.1 model, recombinant mouse IFN- was administered to BC1 B7.1 mice. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the role of IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in the induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "in this B7.1 model,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C3161035:Model [Intellectual Product]
   734   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1366561:B7-1 [Gene or Genome]
   734   C1705431:B7-1 [Gene or Genome]

Phrase: "recombinant mouse IFN-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1522537:Recombinant Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "administered to BC1 B7.1 mice."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   774   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C1366561:B7-1 [Gene or Genome]
   774   C1705431:B7-1 [Gene or Genome]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C1521801:Administered [Functional Concept]
   714 E C1621583:Administer [Functional Concept]
Processing 00000000.tx.136: Of the 10 BC1 B7.1 mice, 4 developed diabetes in a similar time period when compared with the survival curve using poly I:C alone (P = 0.12 for the IFN- group compared with the poly I:C group) (Fig. 7). 

Phrase: "Of the 10 BC1 B7.1 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "4 developed diabetes in a similar time period"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]

Phrase: "when"

Phrase: "compared with the survival curve"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0038952:Survival [Activity]
   760   C0205134:Curve [Spatial Concept]
   760   C0220921:survival [Functional Concept]
   760   C1707455:Compared [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "poly I:C alone"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205171:Alone [Quantitative Concept]
   812   C0439044:alone [Finding]
   812   C0679994:alone [Group Attribute]
   756   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   708   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(P = 0.12 for the IFN- group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   774   C0441849:Group P [Intellectual Product]
   774   C1959644:P group [Clinical Attribute]
   748   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
   748   C2603361:P' [Clinical Attribute]

Phrase: "compared with the poly I:C group"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   814   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   778   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   774   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   774   C0441837:Group C [Classification]
   774   C0441843:Group I [Intellectual Product]
   774   C1959640:I group [Clinical Attribute]
   748   C0021966:I- [Inorganic Chemical]
   748   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C0747726:POLY [Conceptual Entity]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
   748   C1707455:Compared [Activity]

Phrase: ")"

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.137: View larger version (19K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.138: 7. 

Phrase: "7."
Processing 00000000.tx.139: Diabetes survival curve in BC1(x BALB/c) B7.1 mice given 10-day treatment of recombinant mouse IFN-, tetanus toxoid peptide, or poly I:C. 

Phrase: "Diabetes survival curve in BC1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0038952:Survival [Activity]
   753   C0205134:Curve [Spatial Concept]
   753   C0220921:survival [Functional Concept]

Phrase: "(x BALB/c) B7.1 mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   885   C0025919:Mice, BALB C [Mammal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "10-day treatment of recombinant mouse IFN-,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "tetanus toxoid peptide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   734   C0039620:Tetanus toxoid [Immunologic Factor,Pharmacologic Substance]
   734   C0305062:Tetanus Toxoid [Immunologic Factor,Pharmacologic Substance]
   734   C2699384:Tetanus Toxoid [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "poly I:C."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.140: - -- -, IFN- (n = 10); 

Phrase: "-"

Phrase: "-"

Phrase: "- -"

Phrase: ","

Phrase: "IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(n = 10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.141: , tetanus toxoid (n = 10); 

Phrase: ", tetanus toxoid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039620:Tetanus toxoid [Immunologic Factor,Pharmacologic Substance]
  1000   C0305062:Tetanus Toxoid [Immunologic Factor,Pharmacologic Substance]
  1000   C2699384:Tetanus Toxoid [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0039614:Tetanus [Disease or Syndrome]
   861   C0040555:Toxoid [Immunologic Factor,Pharmacologic Substance]

Phrase: "(n = 10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.142: , poly I:C (n = 50).  

Phrase: ", poly I:C (n = 50"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   853   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   840   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0021966:I- [Inorganic Chemical]
   804   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0747726:POLY [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.143: CD4- and CD8-positive staining in islets of poly I:Cinduced diabetic mice. 

Phrase: "CD4-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541261:CD4 [Laboratory Procedure]

Phrase: "and"

Phrase: "CD8-positive staining in islets of poly I:Cinduced diabetic mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0487602:Staining [Laboratory Procedure]
   738   C1704680:Staining [Finding]
Processing 00000000.tx.144: Lymphocytic infiltration of the islets (insulitis) is a hallmark of autoimmune type 1A diabetes. 

Phrase: "Lymphocytic infiltration of the islets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1262091:lymphocytic infiltration [Disease or Syndrome]
   760   C0024264:Lymphocytic [Cell]
   760   C0332448:Infiltration [Pathologic Function]
   760   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   760   C1523986:Infiltration [Functional Concept]
   760   C2939172:Lymphocytic [Qualitative Concept]

Phrase: "(insulitis"

Phrase: ")"

Phrase: "is"

Phrase: "a hallmark of autoimmune type 1A diabetes."
Processing 00000000.tx.145: Poly I:Ctreated mice displayed the characteristic CD4 and CD8 T-cell infiltrate in the islets of the pancreas at the time of diabetes onset (Fig. 8A and B). 

Phrase: "Poly I:Ctreated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "the characteristic CD4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541261:CD4 [Laboratory Procedure]

Phrase: "and"

Phrase: "CD8 T-cell infiltrate in the islets of the pancreas"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0332448:Infiltrate [Pathologic Function]
   739   C1546677:Infiltrate [Intellectual Product]
   739   C1549537:Infiltrate [Functional Concept]

Phrase: "at the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of diabetes onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332162:Onset [Qualitative Concept]

Phrase: "(Fig. 8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.146: The pancreas in mice that developed diabetes after the administration of recombinant mouse IFN- also showed a similar pattern of insulitis (Fig. 8C and D). 

Phrase: "The pancreas in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1518865:Mouse Pancreas [Tissue]
   770   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   770   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "that developed diabetes after the administration of recombinant mouse IFN- also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0011847:Diabetes [Disease or Syndrome]
   738   C0011849:Diabetes [Disease or Syndrome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a similar pattern of insulitis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "(Fig. 8C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.147: In contrast, mice that were given monoclonal antibody to IFN- to block poly I:C disease induction showed no evidence of CD4 and CD8 infiltration when killed at the age of 30 weeks (Fig. 8E and F). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "were"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "monoclonal antibody to IFN- to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "poly I:C disease induction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0205263:Induction [Functional Concept]
   804   C0857127:induction [Therapeutic or Preventive Procedure]
   717   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no evidence of CD4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "and"

Phrase: "CD8 infiltration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332448:Infiltration [Pathologic Function]
   861   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   861   C1523986:Infiltration [Functional Concept]

Phrase: "when"

Phrase: "killed at the age of 30 weeks"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0001779:Age [Organism Attribute]
   748   C0162388:killed [Social Behavior]
   748   C0439230:weeks [Temporal Concept]
   714 E C0332174:/week [Temporal Concept]
   714 E C0681205:Kill [Idea or Concept]
   714 E C1550555:kill [Functional Concept]

Phrase: "(Fig. 8E"

Phrase: "and"

Phrase: "F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.148: Interestingly, mice that did not develop diabetes with poly I:C administration when studied at 40 weeks of age did not show any evidence of insulitis (Fig. 8G and H), suggesting an "all or none" phenomenon in this model of poly I:Cinduced diabetes. 

Phrase: "Interestingly,"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "develop"

Phrase: "diabetes with poly I:C administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]

Phrase: "when"

Phrase: "studied at 40 weeks of age"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0001779:Age [Organism Attribute]
   753   C0439230:weeks [Temporal Concept]
   753   C0439509:/40 [Temporal Concept]
   719 E C0332174:/week [Temporal Concept]
   719   C0557651:Study [Manufactured Object]
   719   C2603343:Study [Research Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "any evidence of insulitis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "(Fig. 8G"

Phrase: "and"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "an ""all or none"" phenomenon in this model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "of poly I:Cinduced diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.149: View larger version (131K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(131K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.150: 8. 

Phrase: "8."
Processing 00000000.tx.151: A and B: CD4 and CD8 pancreatic islet staining of a diabetic BC1(x BALB/c) B7.1 mouse that was given poly I:C. 

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "CD4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541261:CD4 [Laboratory Procedure]

Phrase: "and"

Phrase: "CD8 pancreatic islet staining of a diabetic BC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0487602:Staining [Laboratory Procedure]
   742   C1704680:Staining [Finding]

Phrase: "(x BALB/c) B7.1 mouse"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   885   C0025919:BALB/c Mouse [Mammal]
   799   C0025914:Mouse [Mammal]
   799   C0025929:mouse [Mammal]
   799   C0026809:Mouse [Mammal]

Phrase: "that"

Phrase: "was"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "poly I:C."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.152: C and D: CD4 and CD8 staining of a diabetic BC1(x BALB/c) B7.1 mouse that was given mouse IFN-. 

Phrase: "C"

Phrase: "and"

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "CD4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541261:CD4 [Laboratory Procedure]

Phrase: "and"

Phrase: "CD8 staining of a diabetic BC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]

Phrase: "(x BALB/c) B7.1 mouse"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   885   C0025919:BALB/c Mouse [Mammal]
   799   C0025914:Mouse [Mammal]
   799   C0025929:mouse [Mammal]
   799   C0026809:Mouse [Mammal]

Phrase: "that"

Phrase: "was"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "mouse IFN-."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.153: E and F: CD4 and CD8 pancreatic islet staining of a nondiabetic BC1(x BALB/c) B7.1 mouse killed at 30 weeks of age that was given poly I:C simultaneously with monoclonal antibody to mouse IFN-. 

Phrase: "E"

Phrase: "and"

Phrase: "F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: ":"

Phrase: "CD4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541261:CD4 [Laboratory Procedure]

Phrase: "and"

Phrase: "CD8 pancreatic islet staining of a nondiabetic BC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0487602:Staining [Laboratory Procedure]
   742   C1704680:Staining [Finding]

Phrase: "(x BALB/c) B7.1 mouse"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   885   C0025919:BALB/c Mouse [Mammal]
   799   C0025914:Mouse [Mammal]
   799   C0025929:mouse [Mammal]
   799   C0026809:Mouse [Mammal]

Phrase: "killed at 30 weeks of age"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0162388:killed [Social Behavior]
   753   C0439230:weeks [Temporal Concept]
   719 E C0332174:/week [Temporal Concept]
   719 E C0681205:Kill [Idea or Concept]
   719 E C1550555:kill [Functional Concept]

Phrase: "that"

Phrase: "was"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "poly I:C simultaneously with monoclonal antibody"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   814   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   778   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   774   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   774   C0221138:I not otherwise specified Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           I NOS
   774   C0368815:antibody c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0370188:i Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0521115:simultaneously [Temporal Concept]
   748   C0746619:monoclonal [Finding]
   748   C0747726:POLY [Conceptual Entity]

Phrase: "to mouse IFN-."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.154: G and H: CD4 and CD8 pancreatic islet staining of a nondiabetic BC1(x BALB/c) B7.1 mouse at 40 weeks of age despite poly I:C administration.   

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "CD4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541261:CD4 [Laboratory Procedure]

Phrase: "and"

Phrase: "CD8 pancreatic islet staining of a nondiabetic BC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0487602:Staining [Laboratory Procedure]
   742   C1704680:Staining [Finding]

Phrase: "(x BALB/c) B7.1 mouse at 40 weeks"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   784   C0025919:BALB/c Mouse [Mammal]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]

Phrase: "of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "despite poly I:C administration."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001554:Administration [Occupational Activity]
   812   C1533734:Administration [Therapeutic or Preventive Procedure]
   756   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   708   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.155: DISCUSSION TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Viruses are considered important environmental agents that may initiate -cell destruction in genetically susceptible individuals (6). 

Phrase: "DISCUSSION TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Viruses"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042776:Viruses [Virus]
  1000   C0521026:viruses [Functional Concept]
   966 E C0319157:virus [Virus]

Phrase: "are"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "important environmental agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0336535:Environmental agent [Physical Object]
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]

Phrase: "that"

Phrase: "may"

Phrase: "initiate -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "cell destruction in genetically susceptible individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1261381:Destruction [Therapeutic or Preventive Procedure]
   753   C1948029:Destruction [Activity]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.156: The double-stranded RNA viral mimic poly I:C has been extensively used in various experimental models to mimic part of the pathophysiology of viral infections. 

Phrase: "The double-stranded RNA"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0035693:RNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   865   C1979882:Double strand [Qualitative Concept]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205173:Double [Functional Concept]
   827   C1705764:Double [Activity]
   827   C1705765:Double [Qualitative Concept]
   755   C1704972:Strand [Spatial Concept]
   755   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "viral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521026:Viral [Functional Concept]

Phrase: "mimic"

Phrase: "poly I:C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "has"

Phrase: "been"

Phrase: "extensively"

Phrase: "used in various experimental models to"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0086272:Models, Experimental [Intellectual Product]
   753   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   753   C1273517:used [Finding]
   753   C1517586:Experimental [Qualitative Concept]
   753   C3161035:Models [Intellectual Product]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "mimic"

Phrase: "part of the pathophysiology of viral infections."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1292711:Part of [Spatial Concept]
   748   C0449719:Part [Spatial Concept]
   748   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.157: In this study, we investigated the mechanisms of poly I:Cinduced diabetes using BL/6 mice that express the B7.1 costimulatory molecule in the pancreatic islets. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the mechanisms of poly I:Cinduced diabetes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BL/6 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "express"

Phrase: "the B7.1 costimulatory molecule in the pancreatic islets."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C0104998:B7-1 Costimulatory Molecule [Amino Acid, Peptide, or Protein,Immunologic Factor]
   764   C2985420:Costimulatory Molecule [Amino Acid, Peptide, or Protein]
   742   C0567416:Molecule [Substance]
Processing 00000000.tx.158: This study confirms our previous report that the sensitivity to induce diabetes using poly I:C is lost when the B7.1 transgene on a C57BL/6 background is backcrossed onto BALB/c mice (20). 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "our previous"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205156:Previous [Temporal Concept]
  1000   C1552607:previous [Temporal Concept]

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the sensitivity to"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   964   C0332324:Sensitive to [Functional Concept]
       E   Sensitive
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   789 E C1550474:sensitive [Idea or Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "poly I:C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: "when"

Phrase: "the B7.1 transgene on a C57BL/6 background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0282641:Transgene [Gene or Genome]

Phrase: "is"

Phrase: "backcrossed onto BALB/c mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0025919:Mice, BALB C [Mammal]
           BALB/C
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.159: To investigate the pathway that may be responsible for the diabetes phenotype related to poly I:C sensitivity, IFN- response was studied. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "responsible for the diabetes phenotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "related to poly I:C sensitivity,"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   833   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   790   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   783   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0021966:I- [Inorganic Chemical]
   753   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C0747726:POLY [Conceptual Entity]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]
   748   C0332324:Sensitive to [Functional Concept]
   719 E C0163712:Relate [Organic Chemical]

Phrase: "IFN- response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.160: It was interesting to note that the presence of B7.1 in the islet -cells is critical for a robust IFN- response to poly I:C. 

Phrase: "It"

Phrase: "was"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the presence of B7.1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the islet -cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   966 E C1522529:Islet Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "critical for a robust IFN- response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511545:Critical [Qualitative Concept]

Phrase: "to poly I:C."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.161: Lymphoid cells from the spleen can be a source of IFN- induction in our diabetes induction model with poly I:C. 

Phrase: "Lymphoid cells from the spleen"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0086574:Lymphoid Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C1518071:Lymphoid [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "be"

Phrase: "a source of IFN- induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449416:Source [Finding]
   760   C1705919:Source [Idea or Concept]

Phrase: "in our diabetes induction model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "with poly I:C."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.162: IFN- produced primarily by plasmacytoid dendritic cells is a potent component of the antiviral innate immune response and modulates adaptive immunity (22). 

Phrase: "IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "produced"

Phrase: "primarily by plasmacytoid dendritic cells"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   862   C1956385:Plasmacytoid Dendritic Cells [Cell]
   806   C0011306:Dendritic Cells [Cell]
   781   C0333825:Plasmacytoid cell [Cell]
   773 E C0003315:Dendritic cell [Cell]
   773 E C1511762:Dendritic Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0011305:Dendritic [Cell Component]
   760   C0439640:Dendritic [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "a potent component of the antiviral innate immune response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0449432:Component [Manufactured Object]
   742   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "adaptive immunity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0678209:Adaptive Immunity [Physiologic Function]
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.163: Primary control of IFN- production occurs at a cellular level and is highly dependent upon regulatory factors and their products. 

Phrase: "Primary control of IFN- production"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "occurs at a cellular level"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "is"

Phrase: "highly dependent upon regulatory factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "their products."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.164: One potential explanation for a higher IFN- response seen in mice with the islet RIP B7.1 transgene compared with mice without the B7.1 transgene is that B7.1 acts as an enhancer of immune activation within islets or nonislet tissues (23). 

Phrase: "One potential explanation for a higher IFN- response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0681841:Explanation [Intellectual Product]

Phrase: "seen in mice"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "with the islet RIP B7.1 transgene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   877   C1514735:Rat Transgene [Research Activity]
   795   C0282641:Transgene [Gene or Genome]
   710   C1416480:ISLET 1 [Gene or Genome]

Phrase: "compared with mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C1707455:Compared [Activity]

Phrase: "without the B7.1 transgene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0282641:Transgene [Gene or Genome]
   734   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1366561:B7-1 [Gene or Genome]
   734   C1705431:B7-1 [Gene or Genome]

Phrase: "is"

Phrase: "that B7.1 acts as an enhancer of immune activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "within islets"

Phrase: "or"

Phrase: "nonislet tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.165: It is known that B7.1 can transform nonprofessional antigen-presenting cells (APCs), such as islets, into competent APCs that trigger autoimmunity when additional factors such as local inflammation (24), upregulated major histocompatibility complex Ag expression (25), or high numbers of potentially autoreactive T-cells (26) are present. 

Phrase: "It"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that B7.1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1366561:B7-1 [Gene or Genome]
  1000   C1705431:B7-1 [Gene or Genome]

Phrase: "can"

Phrase: "transform"

Phrase: "nonprofessional antigen-presenting cells (APCs),"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   923   C0003315:Antigen-Presenting Cells [Cell]
   812   C0003320:Antigen [Immunologic Factor]
   812   C0007634:Cells [Cell]
   812   C0449450:Presenting [Idea or Concept]
   812   C3282337:Cells [Cell]
   779 E C0150312:Present [Quantitative Concept]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   712 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "such as islets,"

Phrase: "into competent APCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   923   C0003315:Antigen-Presenting Cells [Cell]
   812   C0003320:Antigen [Immunologic Factor]
   812   C0007634:Cells [Cell]
   812   C0449450:Presenting [Idea or Concept]
   812   C3282337:Cells [Cell]
   779 E C0150312:Present [Quantitative Concept]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   712 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "that"

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "autoimmunity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004368:Autoimmunity [Pathologic Function]
   928 E C0443146:Autoimmune [Pathologic Function]

Phrase: "when"

Phrase: "additional factors such as local inflammation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "(24"

Phrase: ")"

Phrase: ","

Phrase: "upregulated"

Phrase: "major histocompatibility complex Ag expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   717   C0024518:Major Histocompatibility Complex [Gene or Genome]
   717   C1753349:Major histocompatibility complex [Cell Component]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "high numbers of potentially autoreactive T-cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "(26"

Phrase: ")"

Phrase: "are"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.166: Therefore, disease induction by IFN- may require both immune system activation and target organ inflammation, such as -cell major histocompatibility complex class I upregulation, as suggested by a recent report by Zinkernagel et al. 

Phrase: "Therefore,"

Phrase: "disease induction by IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "require"

Phrase: "both immune system activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1879547:Activation [Activity]
   734   C0020962:Immune system [Body System]
   734   C1291764:IMMUNE SYSTEM [Finding]

Phrase: "and"

Phrase: "target organ inflammation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021368:Inflammation [Pathologic Function]

Phrase: "such as -cell major histocompatibility complex class I upregulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0041904:Up-Regulation [Cell Function,Molecular Function]
   795   C0162493:Up-Regulation [Genetic Function]

Phrase: "as"

Phrase: "suggested by a recent report"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0332185:Recent [Temporal Concept]
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C3273238:Report [Intellectual Product]
   726   C1705535:Suggest [Idea or Concept]

Phrase: "by Zinkernagel et al."
Processing 00000000.tx.167: (27). 

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.168: The expression of IFN- appears to reflect an important biological activity in these mice. 

Phrase: "The expression of IFN-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "an important biological activity in these mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0005532:Biological [Biomedical Occupation or Discipline]
   748   C0205177:Activity [Functional Concept]
   748   C0205460:biological [Qualitative Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.169: A higher peak IFN- is observed in diabetic compared with nondiabetic mice. 

Phrase: "A higher peak IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "is"

Phrase: "observed in diabetic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0241863:DIABETIC [Finding]
   790   C1441672:Observed [Functional Concept]

Phrase: "compared with nondiabetic mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1707455:Compared [Activity]
Processing 00000000.tx.170: Furthermore, the level of poly I:Cinduced IFN- predicts diabetes in both the frequency and time to onset of diabetes. 

Phrase: "Furthermore,"

Phrase: "the level of poly I:Cinduced IFN-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0441925:Level I [Intellectual Product]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "predicts"

Phrase: "diabetes in both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]

Phrase: "the frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: "and"

Phrase: "time to onset of diabetes."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   835   C0449244:Time of onset [Temporal Concept]
           onset time
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.171: Earlier onset of diabetes is correlated to a higher peak IFN- level. 

Phrase: "Earlier onset of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C1833334:Early-onset [Finding]
   770   C0332162:Onset [Qualitative Concept]

Phrase: "is"

Phrase: "correlated to a higher peak IFN- level."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   774   C0444505:Peak level [Quantitative Concept]
           Peak
   748   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C1547707:Level [Geographic Area]
   748   C1707520:Correlated [Qualitative Concept]
   748   C2946261:Level [Pharmacologic Substance]
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.172: While it is possible that induced IFN- is only a reflection of islet inflammation in pre-diabetic mice, our data incriminate IFN- in playing a role in disease pathogenesis. 

Phrase: "While"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that induced IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "is"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a reflection of islet inflammation"

Phrase: "in pre-diabetic mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0362046:pre-diabetic [Disease or Syndrome]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "incriminate"

Phrase: "IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in playing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:playing [Daily or Recreational Activity]
  1000   C0600138:playing [Finding]

Phrase: "a role in disease pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.173: The data provide evidence that the pathway of poly I:Cinduced diabetes in this model is IFN- dependent. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the pathway of poly I:Cinduced diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]

Phrase: "in this model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "is"

Phrase: "IFN- dependent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0851827:Dependent [Qualitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]
Processing 00000000.tx.174: The neutralization of IFN- with a monoclonal antibody suppressed the incidence of poly I:Cinduced diabetes in the BL/6 B7.1 mice. 

Phrase: "The neutralization of IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1578828:Neutralization [Laboratory Procedure]
   770   C2987668:Neutralization [Functional Concept]

Phrase: "with a monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "the incidence of poly I:Cinduced diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0021149:Incidence [Quantitative Concept]
   748   C0220856:incidence [Functional Concept]

Phrase: "in the BL/6 B7.1 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.175: Also, the administration of IFN- alone, similar to poly I:C alone, is capable of inducing diabetes in this model. 

Phrase: "Also,"

Phrase: "the administration of IFN- alone, similar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0001554:Administration [Occupational Activity]
   753   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "to poly I:C alone,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205171:Alone [Quantitative Concept]
   812   C0439044:alone [Finding]
   812   C0679994:alone [Group Attribute]
   756   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   708   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "capable of inducing diabetes"

Phrase: "in this model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]
Processing 00000000.tx.176: Furthermore, we have shown that the islet cells of the B7.1-positive mice were not the main cells responsible for IFN- production. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the islet cells of the B7.1-positive mice"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   764   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   762   C0439178:% positive cells [Quantitative Concept]
   762   C1416480:ISLET 1 [Gene or Genome]
   751   C1522528:Mouse Islet Cell [Tissue]
   745   C0007634:THE CELL [Cell]
           Cells
   742   C3282337:Cells [Cell]
   731 E C1522529:Islet Cell [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the main cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "responsible for IFN- production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]
Processing 00000000.tx.177: It is clear from our study that IFN- could not be detected after only 1 day of poly I:C administration, but once the mouse was primed with poly I:C for 5 days, IFN- levels could be detected. 

Phrase: "It"

Phrase: "is"

Phrase: "clear from our"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2963144:Clear [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "that IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "detected after only 1 day of poly I:C administration,"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   782   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   760   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   757   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   757   C0963236:I-1 [Amino Acid, Peptide, or Protein,Receptor]
   757   C1425233:I-1 [Gene or Genome]
   757   C3540559:I-1 [Gene or Genome]
   739   C0001554:Administration [Occupational Activity]
   739   C0021966:I- [Inorganic Chemical]
   739   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0205171:Only [Quantitative Concept]
   739   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0332173:/day [Temporal Concept]
   739   C0439228:day [Temporal Concept]
   739   C0439505:/day [Temporal Concept]
   739   C0442726:Detected [Finding]
   739   C0747726:POLY [Conceptual Entity]
   739   C1511790:Detected [Therapeutic or Preventive Procedure]
   739   C1533734:Administration [Therapeutic or Preventive Procedure]
   739   C1720467:Only [Intellectual Product]

Phrase: "but"

Phrase: "once"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720092:Once [Intellectual Product]
  1000   C1948045:Once [Temporal Concept]

Phrase: "the mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "was"

Phrase: "primed with poly I:C"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   806   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   797   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0021966:I- [Inorganic Chemical]
   760   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0747726:POLY [Conceptual Entity]
   760   C0871133:primed [Functional Concept]

Phrase: "for 5 days,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442466:5 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "IFN- levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "could"

Phrase: "be"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.178: IFN- is used in the treatment of persistent hepatitis B and C infections and various malignancies (28). 

Phrase: "IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "is"

Phrase: "used in the treatment of persistent hepatitis B"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   770   C0019163:Hepatitis B [Disease or Syndrome]
   750   C1524063:Use of [Functional Concept]
   744   C0019158:Hepatitis [Disease or Syndrome]
   744   C0019159:hepatitis [Disease or Syndrome]
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C0205322:Persistent [Temporal Concept]
   744   C0795623:hepatitis [Immunologic Factor,Pharmacologic Substance]
   744   C1273517:used [Finding]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "C infections"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0009450:Infections [Disease or Syndrome]
   777 E C0439663:Infected [Functional Concept]
   745 E C0030657:infectivity [Qualitative Concept]

Phrase: "and"

Phrase: "various malignancies"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0006826:MALIGNANCIES [Neoplastic Process]
   827 E C1306459:Malignancy [Finding]
   777 E C0205282:Malignant [Qualitative Concept]
   777 E C0334590:MALIGNANT [Neoplastic Process]
   777 E C1533592:MALIGNANT [Neoplastic Process]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.179: IFN- has antiviral, cytostatic, and prominent immunomodulatory effects, all of which are of great importance during viral infections. 

Phrase: "IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "has"

Phrase: "antiviral, cytostatic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010858:cytostatic [Pharmacologic Substance]

Phrase: "and"

Phrase: "prominent immunomodulatory effects,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "all of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: "are of great importance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0549177:Great [Quantitative Concept]
   770   C1551058:Are [Quantitative Concept]
   770   C1704243:Great [Quantitative Concept]

Phrase: "during viral infections."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0042769:Viral Infections [Disease or Syndrome]
   861   C0009450:Infections [Disease or Syndrome]
   861   C0521026:Viral [Functional Concept]
   777 E C0439663:Infected [Functional Concept]
   745 E C0030657:infectivity [Qualitative Concept]
Processing 00000000.tx.180: However, prolonged exposure of the immune system to type 1 IFN in the treatment of such diseases can break tolerance and initiate an autoimmune reaction, eventually leading to autoimmune disease. 

Phrase: "However,"

Phrase: "prolonged exposure of the immune system"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0332157:Exposure [Clinical Attribute]
   753   C0439590:Prolonged [Temporal Concept]

Phrase: "to type 1 IFN"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0441729:Type 1 [Classification]

Phrase: "in the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of such diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "can"

Phrase: "break"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881704:BREAK [Phenomenon or Process]

Phrase: "tolerance"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0013220:Tolerance [Finding]
  1000   C0020963:Tolerance [Pathologic Function]
  1000   C0220929:tolerance [Mental Process]
  1000   C0231197:Tolerance [Physiologic Function]
  1000   C1704410:Tolerance [Qualitative Concept]
   944 E C0680282:toleration [Social Behavior]
   928 E C0231198:Tolerant [Functional Concept]

Phrase: "and"

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "an autoimmune reaction,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0443146:Autoimmune reaction [Pathologic Function]
  1000   C1963070:Autoimmune reaction [Finding]
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "eventually"

Phrase: "leading to autoimmune disease."
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   833   C0004364:Autoimmune Disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0332152:Leading [Temporal Concept]
   770   C0443146:Autoimmune [Pathologic Function]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.181: Autoimmune diseases implicated with IFN- therapy include thyroiditis, autoimmune gastritis, psoriasis, systemic lupus erythematosis, and rheumatoid arthritis (2931). 

Phrase: "Autoimmune diseases"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004364:Autoimmune Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0443146:Autoimmune [Pathologic Function]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "implicated with IFN- therapy"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0279030:interferon therapy [Therapeutic or Preventive Procedure]
   770   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0039798:therapy [Functional Concept]
   770   C0087111:Therapy [Therapeutic or Preventive Procedure]
   770   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1363945:Therapy [Finding]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "thyroiditis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040147:Thyroiditis [Disease or Syndrome]

Phrase: "autoimmune gastritis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017154:Autoimmune gastritis [Disease or Syndrome]
   861   C0017152:Gastritis [Disease or Syndrome]
   861   C0443146:Autoimmune [Pathologic Function]

Phrase: "psoriasis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033860:Psoriasis [Disease or Syndrome]

Phrase: "systemic lupus erythematosis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024141:SYSTEMIC LUPUS ERYTHEMATOSIS [Disease or Syndrome]
           LUPUS ERYTHEMATOSIS (NOS)

Phrase: "and"

Phrase: "rheumatoid arthritis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]

Phrase: "(2931"

Phrase: ")."
Processing 00000000.tx.182: In addition, there have been numerous case reports of type 1A diabetes or islet autoantibody expression with IFN- therapy (7). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "there"

Phrase: "have"

Phrase: "been"

Phrase: "numerous case reports of type 1A diabetes"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   789   C0585733:Type of Report [Intellectual Product]
           Report type
   778   C0007320:Case Reports [Intellectual Product]
   748   C0684224:Reports [Intellectual Product]
   748   C0700287:reports [Health Care Activity]
   748   C0868928:Case [Functional Concept]
   748   C1706255:CASE [Medical Device]
   748   C1706256:Case [Conceptual Entity]
   745 E C0085973:Case Report [Intellectual Product]
   714 E C3273238:Report [Intellectual Product]

Phrase: "or"

Phrase: "islet autoantibody expression with IFN- therapy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.183: Our current data suggest that IFN- serves as a link between the innate response to poly I:C and the adaptive immune response that eventually leads to the induction of autoimmune diabetes. 

Phrase: "Our current data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "serves as a link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1517892:Link [Intellectual Product]
   770   C1704666:Link [Intellectual Product]

Phrase: "between the innate response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "to poly I:C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "the adaptive immune response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1749719:Adaptive Immune Response [Organism Function]
   901   C0301872:Immune response [Organ or Tissue Function]
   827   C0439662:Immune [Functional Concept]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "that eventually"

Phrase: "leads to the induction of autoimmune diabetes."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0205734:Diabetes, Autoimmune [Disease or Syndrome]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0181586:leads [Medical Device]
   748   C0205263:Induction [Functional Concept]
   748   C0443146:Autoimmune [Pathologic Function]
   748   C0857127:induction [Therapeutic or Preventive Procedure]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.184: In tissue culture, IFN- can decrease insulin synthesis and secretion (32,33). 

Phrase: "In tissue culture,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0040284:Tissue culture [Laboratory Procedure]
   861   C0010453:Culture [Idea or Concept]
   861   C0040300:Tissue [Tissue]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1547928:Tissue [Intellectual Product]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "can"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "insulin synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "(32,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.185: Furthermore, human -cells show a marked induction of oligoadenylate synthase (marker of apoptosis induction) with IFN- (34). 

Phrase: "Furthermore,"

Phrase: "human -cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0427861:Human cells [Laboratory or Test Result]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a marked induction of oligoadenylate synthase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "(marker of apoptosis induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0005516:Marker [Clinical Attribute]
   715   C3266896:Induction of Apoptosis [Cell Function]

Phrase: ")"

Phrase: "with IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.186: IFN- can also have a direct cytolytic effect on -cells or an indirect effect by activating the innate immune system (7). 

Phrase: "IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "can"

Phrase: "also"

Phrase: "have"

Phrase: "a direct cytolytic effect on -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "an indirect effect by activating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "the innate immune system"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0020962:Immune system [Body System]
   901   C1291764:IMMUNE SYSTEM [Finding]
   827   C0439662:Immune [Functional Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.187: In one particular study, investigators evaluated the expression of messenger RNA for a series of cytokines in the pancreas and islets of patients with and without type 1A diabetes. 

Phrase: "In one particular study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "investigators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035173:Investigators [Professional or Occupational Group]

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the expression of messenger RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0040649:RNA Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "for a series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "of cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in the pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "islets of patients"

Phrase: "with"

Phrase: "and without type 1A diabetes."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C0450344:1A [Intellectual Product]
   760   C1515981:And [Idea or Concept]
   760   C1547052:*Type [Quantitative Concept]
   760   C1553633:1a [Medical Device]
Processing 00000000.tx.188: They found that only IFN- was significantly overexpressed in diabetic patients (9). 

Phrase: "They"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that only IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "significantly"

Phrase: "overexpressed in diabetic patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0241863:DIABETIC [Finding]
   737   C1514559:overexpress [Genetic Function]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.189: Elevated IFN- levels have also been documented in the serum of adult diabetic patients (35,36). 

Phrase: "Elevated IFN- levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "documented in the serum of adult diabetic patients"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   744   C0001675:Adult [Age Group]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0229671:Serum [Body Substance]
   744   C0241863:DIABETIC [Finding]
   744   C1301725:Documented [Health Care Activity]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
   744   C1609436:documented [Idea or Concept]
   744   C1706450:Adult [Human]
   711 E C1301746:document [Intellectual Product]
   711 E C1547673:Document [Intellectual Product]

Phrase: "(35,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.190: In almost all cases of new-onset type 1A diabetes, pancreatic -cells contained IFN-, which correlated with overexpression of the IFN- gene (37). 

Phrase: "In almost"

Phrase: "all cases of new-onset type 1A diabetes,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C0868928:Cases [Functional Concept]
   744   C1533148:Cases [Quantitative Concept]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]

Phrase: "pancreatic -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "IFN-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "which"

Phrase: "correlated with overexpression of the IFN- gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0017337:Gene [Gene or Genome]
   748   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C1514559:Overexpression [Genetic Function]
   748   C1707520:Correlated [Qualitative Concept]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.191: We have demonstrated a quantitative correlation of IFN- levels and progression to diabetes in the poly I:C RIP-B7.1induced diabetes model. 

Phrase: "We"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "a quantitative correlation of IFN- levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "progression to diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242656:progression [Pathologic Function]
   790   C0449258:Progression [Functional Concept]

Phrase: "in the poly I:C RIP-B7.1induced diabetes model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3161035:Model [Intellectual Product]
Processing 00000000.tx.192: We speculate that viral infections through the generation of double-stranded RNA may induce IFN- that in turn, in a genetically susceptible individual (e.g., DR3/4-DQ2/DQ8), will trigger anti-islet autoimmunity. 

Phrase: "We"

Phrase: "speculate"

Phrase: "that viral infections through the generation of double-stranded RNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0042769:Viral Infections [Disease or Syndrome]
   757   C0035736:RNA, Viral [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0009450:Infections [Disease or Syndrome]
   739   C0521026:Viral [Functional Concept]

Phrase: "may"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that in turn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "in a genetically susceptible individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "DR3/4-DQ2/DQ8"

Phrase: ")"

Phrase: ","

Phrase: "will"

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "anti-islet autoimmunity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0004368:Autoimmunity [Pathologic Function]
   755 E C0443146:Autoimmune [Pathologic Function]
Processing 00000000.tx.193: Therefore, the response to IFN- may be an important component of type 1A diabetes risk, and pharmacologic regulation of the pathway may be important for disease prevention.  

Phrase: "Therefore,"

Phrase: "the response to IFN-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "may"

Phrase: "be"

Phrase: "an important component of type 1A diabetes risk,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C3645606:Component type [Intellectual Product]
   744   C0449432:Component [Manufactured Object]
   744   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "pharmacologic regulation of the pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "may"

Phrase: "be"

Phrase: "important for disease prevention."
Processing 00000000.tx.194: ACKNOWLEDGMENTS  This research was supported by grants from the National Institutes of Health (NIH) (DK 055969, DK 062718, and AI 055466), the Autoimmunity Prevention Center U19 (AI 050864), the Diabetes Endocrine Research Center (P30 DK57516), the American Diabetes Association, the Juvenile Diabetes Foundation, and the Childrens Diabetes Foundation. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the National Institutes of Health (NIH)"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "(DK 055969,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "DK 062718,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "and"

Phrase: "AI 055466"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003353:AI [Geographic Area]
   861   C0003504:ai [Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "the Autoimmunity Prevention Center U19"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1427926:U19 [Gene or Genome]
   812   C1822888:U19 [Gene or Genome]
   812   C2982442:U19 [Gene or Genome]

Phrase: "(AI 050864"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003353:AI [Geographic Area]
   861   C0003504:ai [Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "the Diabetes Endocrine Research Center"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0683939:research center [Manufactured Object,Organization]
   812   C0205099:Center [Spatial Concept]

Phrase: "(P30 DK57516"

Phrase: ")"

Phrase: ","

Phrase: "the American Diabetes Association,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1705019:American Diabetes Association [Professional Society]
   827   C0004083:Association [Mental Process]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "the Juvenile Diabetes Foundation,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   734   C0011854:Juvenile Diabetes [Disease or Syndrome]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "the Childrens Diabetes Foundation."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.195: D.D. is supported by an Eli Lilly fellowship award, and E.L. is supported by an NIH grant (DK 06405).  

Phrase: "D.D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0112081:D-D [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "supported by an Eli Lilly fellowship award,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0331851:Eli Lilly [Health Care Related Organization]
   748   C0004446:Award [Manufactured Object]
   748   C0015770:Fellowship [Educational Activity]
   748   C1521721:Supported [Conceptual Entity]
   714 E C0183683:Support [Medical Device]

Phrase: "and"

Phrase: "E.L."

Phrase: "is"

Phrase: "supported by an NIH grant"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   744   C0018173:Grant [Quantitative Concept]
   744   C0018684:Health [Idea or Concept]
   744   C0021622:Institutes [Organization]
   744   C1521721:Supported [Conceptual Entity]
   744   C1548284:Grant [Idea or Concept]
   744   C3245503:national [Intellectual Product]
   711 E C0183683:Support [Medical Device]
   711 E C1272753:Institute [Idea or Concept]

Phrase: "(DK 06405"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: ")."
Processing 00000000.tx.196: FOOTNOTES  The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.197: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.198: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.199: Address correspondence and reprint requests to Dr. 

Phrase: "Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Dr."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0031831:DR [Professional or Occupational Group]
   790   C0686900:request [Functional Concept]
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.200: Edwin Liu, MD, Barbara Davis Center for Childhood Diabetes, 4200 East 9th Ave., Box B140, University of Colorado Health Sciences Center, Denver, CO 80262. 

Phrase: "Edwin Liu,"

Phrase: "MD,"

Phrase: "Barbara Davis"

Phrase: "Center for Childhood Diabetes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]
   770   C0205099:Center [Spatial Concept]
   770   C0231335:Childhood [Temporal Concept]

Phrase: "4200 East 9th Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Box B140,"

Phrase: "University of Colorado Health Sciences Center,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   839   C0475309:Health center [Health Care Related Organization,Manufactured Object]
   827   C1512352:Health Sciences [Biomedical Occupation or Discipline]
   799   C0009399:Colorado [Geographic Area]
   799   C0018684:Health [Idea or Concept]
   799   C0036397:Sciences [Occupation or Discipline]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0205099:Center [Spatial Concept]

Phrase: "Denver,"

Phrase: "CO 80262."
Processing 00000000.tx.201: E-mail: edwin.liu{at}uchsc.edu Received for publication January 3, 2005 and accepted in revised form May 3, 2005 IFN, interferon; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "edwin.liu{at}uchsc.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "Received for publication January 3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2005"

Phrase: "and"

Phrase: "accepted in revised form May 3,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1272684:Accepted [Qualitative Concept]
   753   C1522492:Form [Functional Concept]
   753   C1527075:Revised [Therapeutic or Preventive Procedure]
   753   C1548435:Accepted [Idea or Concept]
   719 E C1548601:Accept [Idea or Concept]

Phrase: "2005 IFN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "interferon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.202: poly I:C, polyinosinic:polycytidylic acid; 

Phrase: "poly I:C, polyinosinic:polycytidylic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0032414:Polyinosinic-Polycytidylic Acid [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0001128:Acid [Chemical]
   799   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.203: RIP, rat insulin promoter  REFERENCES TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Castano L, Eisenbarth GS: Type I diabetes: a chronic autoimmune disease of man, mouse, and rat. 

Phrase: "RIP,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "rat insulin promoter"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035171:Research Design [Research Activity]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1707689:Design [Activity]
   812   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Castano L,"

Phrase: "Eisenbarth GS"

Phrase: ":"

Phrase: "Type I diabetes"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type I [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: ":"

Phrase: "a chronic autoimmune disease of man,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004364:Autoimmune Disease [Disease or Syndrome]
   783   C0008679:Chronic disease [Disease or Syndrome]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0443146:Autoimmune [Pathologic Function]

Phrase: "mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]
Processing 00000000.tx.204: Annu Rev Immunol8 :647 679,1990[Medline] Atkinson MA, Maclaren NK: The pathogenesis of insulin-dependent diabetes mellitus. 

Phrase: "Annu Rev Immunol8"

Phrase: ":"

Phrase: "647 679,"

Phrase: "1990"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Atkinson MA,"

Phrase: "Maclaren NK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022688:NK [Cell]

Phrase: ":"

Phrase: "The pathogenesis of insulin-dependent diabetes mellitus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.205: N Engl J Med331 :1428 1436,1994[Free FullText] Bach J-F: Insulin-dependent diabetes mellitus as an autoimmune disease. 

Phrase: "N Engl J Med331"

Phrase: ":"

Phrase: "1428 1436,"

Phrase: "1994"

Phrase: "[Free FullText"

Phrase: "] Bach J-F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: ":"

Phrase: "Insulin-dependent diabetes mellitus as an autoimmune disease."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   770   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   767   C0205734:Diabetes, Autoimmune [Disease or Syndrome]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]
Processing 00000000.tx.206: Endocr Rev15 :516 542,1994[Abstract] Devendra D, Liu E, Eisenbarth GS: Type 1 diabetes: recent developments. 

Phrase: "Endocr Rev15"

Phrase: ":"

Phrase: "516 542,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Devendra D,"

Phrase: "Liu E,"

Phrase: "Eisenbarth GS"

Phrase: ":"

Phrase: "Type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: ":"

Phrase: "recent developments."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0243107:development [Physiologic Function]
   827   C0678723:Development [Organism Function]
   827   C1527148:Development [Functional Concept]
   777 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.207: BMJ328 :750 754,2004[Free FullText] Onkamo P, Vaananen S, Karvonen M, Tuomilehto J: Worldwide increase in incidence of type I diabetes: the analysis of the data on published incidence trends. 

Phrase: "BMJ328"

Phrase: ":"

Phrase: "750 754,"

Phrase: "2004"

Phrase: "[Free FullText"

Phrase: "] Onkamo P,"

Phrase: "Vaananen S,"

Phrase: "Karvonen M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tuomilehto J"

Phrase: ":"

Phrase: "Worldwide"

Phrase: "increase in incidence of type I diabetes"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0011854:Type 1 diabetes [Disease or Syndrome]
   778   C0441729:Type I [Classification]
   774   C1320657:Diabetes type [Finding]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0021149:Incidence [Quantitative Concept]
   748   C0021966:I- [Inorganic Chemical]
   748   C0220856:incidence [Functional Concept]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0332307:Type [Qualitative Concept]
   748   C0442805:Increase [Functional Concept]
   748   C1547052:*Type [Quantitative Concept]
   732   C0220888:increasing incidence [Functional Concept]

Phrase: ":"

Phrase: "the analysis of the data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0010992:Data Analysis [Occupational Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "on published incidence trends."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040833:trends [Temporal Concept]
   827   C1521798:Trends [Temporal Concept]
Processing 00000000.tx.208: Diabetologia42 :1395 1403,1999[Medline] Yoon JW: A new look at viruses in type I diabetes. 

Phrase: "Diabetologia42"

Phrase: ":"

Phrase: "1395 1403,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yoon JW"

Phrase: ":"

Phrase: "A new"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205314:New [Temporal Concept]

Phrase: "look at viruses"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0042776:Viruses [Virus]
   790   C0233426:look [Organism Attribute]
   790   C0521026:viruses [Functional Concept]
   756 E C0319157:virus [Virus]

Phrase: "in type I diabetes."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type I [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.209: Diabete Metab Rev11 :83 108,1995 Devendra D, Eisenbarth GS: Interferon alpha a potential link in the pathogenesis in the viral induced type 1 diabetes and autoimmunity. 

Phrase: "Diabete Metab Rev11"

Phrase: ":"

Phrase: "83 108,"

Phrase: "1995 Devendra D,"

Phrase: "Eisenbarth GS"

Phrase: ":"

Phrase: "Interferon alpha"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0002199:Interferon Alfa [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0751598:Interferon Alfa [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1610033:Interferon Alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2825023:Interferon alfa [Pharmacologic Substance]
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "a potential link in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1517892:Link [Intellectual Product]
   753   C1704666:Link [Intellectual Product]

Phrase: "in the viral induced type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0011854:Type 1 diabetes [Disease or Syndrome]
   853   C1320657:type diabetes [Finding]
   840   C0441729:Type 1 [Classification]
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   804   C0332307:Type [Qualitative Concept]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "autoimmunity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004368:Autoimmunity [Pathologic Function]
   928 E C0443146:Autoimmune [Pathologic Function]
Processing 00000000.tx.210: Clin Immunol111 :225 233,1995 Hyoty H, Taylor KW: The role of viruses in human diabetes. 

Phrase: "Clin Immunol111"

Phrase: ":"

Phrase: "225 233,"

Phrase: "1995 Hyoty H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Taylor KW"

Phrase: ":"

Phrase: "The role of viruses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in human diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.211: Diabetologia45 :1353 1361,2002[Medline] Huang X, Yuan J, Goddard A, Foulis A, James RFL, Lernmark , Pujol-Borrell R, Rabinovitch A, Somoza N, Stewart TA: Interferon expression in the pancreases of patients with type I diabetes. 

Phrase: "Diabetologia45"

Phrase: ":"

Phrase: "1353 1361,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Huang X,"

Phrase: "Yuan J,"

Phrase: "Goddard A,"

Phrase: "Foulis A,"

Phrase: "James RFL,"

Phrase: "Lernmark ,"

Phrase: "Pujol-Borrell R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "Rabinovitch A,"

Phrase: "Somoza N,"

Phrase: "Stewart TA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: ":"

Phrase: "Interferon expression in the pancreases of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "with type I diabetes."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type I [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.212: Diabetes44 :658 664,1995[Abstract] Stewart TA: Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases. 

Phrase: "Diabetes44"

Phrase: ":"

Phrase: "658 664,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Stewart TA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: ":"

Phrase: "Neutralizing"

Phrase: "interferon alpha as a therapeutic approach"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0002199:Interferon Alfa [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C0751598:Interferon Alfa [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C1610033:Interferon Alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C2825023:Interferon alfa [Pharmacologic Substance]
   753   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0439095:Alpha [Intellectual Product]
   753   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C2003941:Alpha [Intellectual Product]
   753   C2350010:Alpha [Qualitative Concept]

Phrase: "to autoimmune diseases."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004364:Autoimmune Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0443146:Autoimmune [Pathologic Function]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.213: Cytokine Growth Factor Rev14 :139 154,2003[Medline] Stauffer Y, Marguerat S, Meylan F, Ucla C, Sutkowski N, Huber B, Pelet T, Conrad B: Interferon-alpha-induced endogenous superantigen: a model linking environment and autoimmunity. 

Phrase: "Cytokine Growth Factor Rev14"

Phrase: ":"

Phrase: "139 154,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stauffer Y,"

Phrase: "Marguerat S,"

Phrase: "Meylan F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Ucla C,"

Phrase: "Sutkowski N,"

Phrase: "Huber B,"

Phrase: "Pelet T,"

Phrase: "Conrad B"

Phrase: ":"

Phrase: "Interferon-alpha-induced endogenous superantigen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0206527:Superantigen [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "a model linking environment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014406:Environment [Spatial Concept]

Phrase: "and"

Phrase: "autoimmunity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004368:Autoimmunity [Pathologic Function]
   928 E C0443146:Autoimmune [Pathologic Function]
Processing 00000000.tx.214: Immunity15 :591 601,2001[Medline] Fabris P, Betterle C, Greggio NA, Zanchetta R, Bosi E, Biasin MR, de Lalla F: Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis. 

Phrase: "Immunity15"

Phrase: ":"

Phrase: "591 601,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fabris P,"

Phrase: "Betterle C,"

Phrase: "Greggio NA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1272460:{NA} [Qualitative Concept]

Phrase: "Zanchetta R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bosi E,"

Phrase: "Biasin MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "de Lalla F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: ":"

Phrase: "Insulin-dependent diabetes mellitus during alpha-interferon therapy"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   793   C0948092:diabetes mellitus therapy [Therapeutic or Preventive Procedure]
   770   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   767   C3274787:Diabetes Therapy [Therapeutic or Preventive Procedure]
   767   C3539002:Diabetes Therapy [Intellectual Product]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]

Phrase: "for chronic viral hepatitis."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0276623:Chronic viral hepatitis [Disease or Syndrome]
   913   C0019189:Hepatitis, Chronic [Disease or Syndrome]
   901   C0042721:Viral hepatitis [Disease or Syndrome]
   901   C1963279:Viral hepatitis [Finding]
   827   C0019158:Hepatitis [Disease or Syndrome]
   827   C0019159:hepatitis [Disease or Syndrome]
   827   C0205191:chronic [Temporal Concept]
   827   C0521026:Viral [Functional Concept]
   827   C0795623:hepatitis [Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.215: J Hepatol28 :514 517,1998[Medline] Huang X, Hultgren B, Dybdal N, Stewart TA: Islet expression of interferon-alpha precedes diabetes in both the BB rat and streptozotocin-treated mice. 

Phrase: "J Hepatol28"

Phrase: ":"

Phrase: "514 517,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Huang X,"

Phrase: "Hultgren B,"

Phrase: "Dybdal N,"

Phrase: "Stewart TA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: ":"

Phrase: "Islet expression of interferon-alpha"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "precedes"

Phrase: "diabetes in both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]

Phrase: "the BB rat"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034699:Rat, BB [Mammal]
   861   C0004739:BB [Geographic Area]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0332297:BB [Spatial Concept]

Phrase: "and"

Phrase: "streptozotocin-treated mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.216: Immunity1 :469 478,1994[Medline] Guidotti LG, Chisari FV: Noncytolytic control of viral infections by the innate and adaptive immune response. 

Phrase: "Immunity1"

Phrase: ":"

Phrase: "469 478,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Guidotti LG,"

Phrase: "Chisari FV"

Phrase: ":"

Phrase: "Noncytolytic control of viral infections"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   781   C0085557:Infection Control [Health Care Activity]
   781   C1555984:Infection Control [Professional or Occupational Group]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "by the innate"

Phrase: "and"

Phrase: "adaptive immune response."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1749719:Adaptive Immune Response [Organism Function]
   901   C0301872:Immune response [Organ or Tissue Function]
   827   C0439662:Immune [Functional Concept]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
Processing 00000000.tx.217: Annu Rev Immunol19 :65 91,2001[Medline] Sobel DO, Newsome J, Ewel CH, Bellanti JA, Abbassi V, Creswell K, Blair O: Poly I:C induces development of diabetes mellitus in BB rat. 

Phrase: "Annu Rev Immunol19"

Phrase: ":"

Phrase: "65 91,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450385:65 [Intellectual Product]

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sobel"

Phrase: "DO"

Phrase: ","

Phrase: "Newsome J,"

Phrase: "Ewel CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]

Phrase: "Bellanti JA,"

Phrase: "Abbassi V,"

Phrase: "Creswell K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Blair O"

Phrase: ":"

Phrase: "Poly I:C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032414:Poly I-C [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   913   C0032408:Poly C [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0032413:Poly I [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "development of diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "in BB rat."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034699:Rat, BB [Mammal]
   861   C0004739:BB [Geographic Area]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0332297:BB [Spatial Concept]
Processing 00000000.tx.218: Diabetes41 :515 520,1992[Abstract] Thomas VA, Woda BA, Handler ES, Greiner DL, Mordes JP, Rossini AA: Altered expression of diabetes in BB/Wor rats by exposure to viral pathogens. 

Phrase: "Diabetes41"

Phrase: ":"

Phrase: "515 520,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Thomas VA,"

Phrase: "Woda BA,"

Phrase: "Handler ES,"

Phrase: "Greiner DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Mordes JP,"

Phrase: "Rossini AA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: ":"

Phrase: "Altered expression of diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "by exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to viral pathogens."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0450254:Pathogen [Organism]
   755 E C0030657:pathogenicity [Qualitative Concept]
   755 E C1136169:Pathogenicity [Organism Attribute]
Processing 00000000.tx.219: Diabetes40 :255 258,1991[Abstract] Serreze DV, Hamaguchi K, Leiter EH: Immunostimulation circumvents diabetes in NOD/Lt mice. 

Phrase: "Diabetes40"

Phrase: ":"

Phrase: "255 258,"

Phrase: "1991"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Serreze DV,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0279354:DV [Therapeutic or Preventive Procedure]
   861   C1704645:DV [Conceptual Entity]

Phrase: "Hamaguchi K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Leiter EH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: ":"

Phrase: "Immunostimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020971:Immunostimulation [Therapeutic or Preventive Procedure]
  1000   C2267003:Immunostimulation [Physiologic Function]

Phrase: "circumvents"

Phrase: "diabetes in NOD/Lt mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.220: J Autoimmun2 :759 776,1989[Medline] Abiru N, Maniatis AK, Yu L, Miao D, Moriyama H, Wegmann D, Eisenbarth GS: Peptide and major histocompatibility complexspecific breaking of humoral tolerance to native insulin with the B9-23 peptide in diabetes-prone and normal mice. 

Phrase: "J Autoimmun2"

Phrase: ":"

Phrase: "759 776,"

Phrase: "1989"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Abiru N,"

Phrase: "Maniatis AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: "Yu L,"

Phrase: "Miao D,"

Phrase: "Moriyama H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Wegmann D,"

Phrase: "Eisenbarth GS"

Phrase: ":"

Phrase: "Peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "major histocompatibility complexspecific breaking of humoral tolerance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1881704:BREAK [Phenomenon or Process]

Phrase: "to native insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "with the B9-23 peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0386280:B9-23 peptide [Amino Acid, Peptide, or Protein]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "in diabetes-prone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
   861   C0033422:Prone [Spatial Concept]

Phrase: "and"

Phrase: "normal mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.221: Diabetes50 :1274 1281,2001[Abstract/Free FullText] Moriyama H, Wen L, Abiru N, Liu E, Yu L, Miao D, Gianani R, Wong FS, Eisenbarth GS: Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. 

Phrase: "Diabetes50"

Phrase: ":"

Phrase: "1274 1281,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Moriyama H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Wen L,"

Phrase: "Abiru N,"

Phrase: "Liu E,"

Phrase: "Yu L,"

Phrase: "Miao D,"

Phrase: "Gianani R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Wong FS,"

Phrase: "Eisenbarth GS"

Phrase: ":"

Phrase: "Induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "acceleration of insulitis/diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0000894:Acceleration [Phenomenon or Process]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "with a viral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521026:Viral [Functional Concept]

Phrase: "mimic"

Phrase: "(polyinosinic-polycytidylic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032414:Polyinosinic-Polycytidylic Acid [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "an insulin self-peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.222: Proc Natl Acad Sci U S A99 :5539 5544,2002[Abstract/Free FullText] Paronen J, Liu E, Moriyama H, Devendra D, Ide A, Taylor R,Yu L, Miao D, Melanitou E, Eisenbarth GS: Genetic differentiation of poly I:C from B:923 peptide induced experimental autoimmune diabetes. 

Phrase: "Proc Natl Acad Sci U S A99"

Phrase: ":"

Phrase: "5539 5544,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Paronen J,"

Phrase: "Liu E,"

Phrase: "Moriyama H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Devendra D,"

Phrase: "Ide A,"

Phrase: "Taylor R,Yu L,"

Phrase: "Miao D,"

Phrase: "Melanitou E,"

Phrase: "Eisenbarth GS"

Phrase: ":"

Phrase: "Genetic differentiation of poly I:C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0917892:Genetic Differentiation [Genetic Function]
   753   C0007589:Differentiation [Cell Function]
   753   C1511938:Differentiation [Clinical Attribute]
   753   C2945687:Differentiation [Functional Concept]

Phrase: "from B:923 peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0070338:b peptide [Amino Acid, Peptide, or Protein]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "experimental autoimmune diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0205734:Diabetes, Autoimmune [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.223: J Autoimmun22 :307 313,2004[Medline] Stewart TA, Hultgren B, Huang X, Pitts-Meek S, Hully J, Maclachlan NJ: Induction of type I diabetes by interferon- in transgenic mice. 

Phrase: "J Autoimmun22"

Phrase: ":"

Phrase: "307 313,"

Phrase: "2004"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stewart TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Hultgren B,"

Phrase: "Huang X,"

Phrase: "Pitts-Meek S,"

Phrase: "Hully J,"

Phrase: "Maclachlan NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: ":"

Phrase: "Induction of type I diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by interferon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.224: Science260 :1942 1946,1993[Medline] Asselin-Paturel C, Boonstra A, Dalod M, Durand I, Yessaad N, Dezutter-Dambuyant C, Vicari A, OGarra A, Biron C, Briere F, Trinchieri G: Mouse type I IFNproducing cells are immature APCs with plasmacytoid morphology. 

Phrase: "Science260"

Phrase: ":"

Phrase: "1942 1946,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Asselin-Paturel C,"

Phrase: "Boonstra A,"

Phrase: "Dalod M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Durand I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Yessaad N,"

Phrase: "Dezutter-Dambuyant C,"

Phrase: "Vicari A,"

Phrase: "OGarra A,"

Phrase: "Biron C,"

Phrase: "Briere F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Trinchieri G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Mouse type I IFNproducing cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   877   C1519720:Type I Cell [Cell]
   858   C0449475:type cell [Intellectual Product]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "immature APCs with plasmacytoid morphology."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   814   C0003315:Antigen-Presenting Cells [Cell]
   774   C2708700:Immature cells [Cell]
   774   C3272950:Immature Cells [Laboratory Procedure]
   757   C0243091:cell morphology [Qualitative Concept]
   757   C0333825:Plasmacytoid cell [Cell]
   757   C1521816:Cell morphology [Clinical Attribute]
   757   C2700385:Cell Morphology [Biomedical Occupation or Discipline]
   748   C0003320:Antigen [Immunologic Factor]
   748   C0007634:Cells [Cell]
   748   C0449450:Presenting [Idea or Concept]
   748   C3282337:Cells [Cell]
   714 E C0150312:Present [Quantitative Concept]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.225: Nat Immunol2 :1144 1150,2001[Medline] Wen L, Peng J, Li Z, Wong FS: The effect of innate immunity on autoimmune diabetes and the expression of toll-like receptors on pancreatic islets. 

Phrase: "Nat Immunol2"

Phrase: ":"

Phrase: "1144 1150,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wen L,"

Phrase: "Peng J,"

Phrase: "Li Z,"

Phrase: "Wong FS"

Phrase: ":"

Phrase: "The effect of innate immunity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on autoimmune diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205734:Diabetes, Autoimmune [Disease or Syndrome]
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "the expression of toll-like receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0597360:receptor expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "on pancreatic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.226: J Immunol172 :3173 3180,2004[Abstract/Free FullText] Guerder S, Picarella DE, Linsley PS, Flavell RA: Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice. 

Phrase: "J Immunol172"

Phrase: ":"

Phrase: "3173 3180,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Guerder S,"

Phrase: "Picarella DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Linsley PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "Flavell RA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: ":"

Phrase: "Costimulator B7-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1366561:B7-1 [Gene or Genome]
   901   C1705431:B7-1 [Gene or Genome]
   827   C0021756:co-stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "confers"

Phrase: "antigen-presenting-cell function to parenchymal tissue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0007613:Cell Function [Cell Function]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "and in conjunction with tumor necrosis factor alpha"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   833   C0041368:tumor necrosis factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
           tumor necrosis factor
   833   C1168005:Tumor Necrosis Factor alpha [Laboratory Procedure]
   833   C1456820:Tumor Necrosis Factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Tumour necrosis factor
   822 E C0812246:TUMOR NECROSIS FACTOR, ALPHA [Gene or Genome]
   800   C1323304:tumor necrosis factor [Molecular Function]
   770   C0333516:Tumor necrosis [Neoplastic Process]
   744   C0027540:Necrosis [Organ or Tissue Function]
   744   C0027651:Tumor [Neoplastic Process]
   744   C0439095:Alpha [Intellectual Product]
   744   C1334928:Necrosis [Finding]
   744   C1515981:And [Idea or Concept]
   744   C1521761:Factor [Functional Concept]
   744   C1578706:Tumor [Intellectual Product]
   744   C2003941:Alpha [Intellectual Product]
   744   C2350010:Alpha [Qualitative Concept]
   744   C2699427:Conjunction [Idea or Concept]
   744   C2827422:Factor [Conceptual Entity]
   744   C3273930:Tumor [Finding]
   731 E C1300818:Necrotic tumor [Neoplastic Process]

Phrase: "leads to autoimmunity"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0004368:Autoimmunity [Pathologic Function]
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0181586:leads [Medical Device]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
   718 E C0443146:Autoimmune [Pathologic Function]

Phrase: "in transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.227: Proc Natl Acad Sci U S A91 :5138 5142,1994[Abstract/Free FullText] Guerder S, Meyerhoff J, Flavell R: The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. 

Phrase: "Proc Natl Acad Sci U S A91"

Phrase: ":"

Phrase: "5138 5142,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "] Guerder S,"

Phrase: "Meyerhoff J,"

Phrase: "Flavell R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "The role of the T cell costimulator B7-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "in autoimmunity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004368:Autoimmunity [Pathologic Function]
   928 E C0443146:Autoimmune [Pathologic Function]

Phrase: "and"

Phrase: "the induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "maintenance of tolerance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0024501:Maintenance [Activity]

Phrase: "to peripheral antigen."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigen [Immunologic Factor]
   761 E C2698667:ANTIGENICITY [Regulation or Law]
Processing 00000000.tx.228: Immunity1 :155 166,1994[Medline] Harlan DM, Hengartner H, Huang ML, Kang YH, Abe R, Moreadith RW, Pircher H, Gray GS, Ohashi PS, Freeman GJ: Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. 

Phrase: "Immunity1"

Phrase: ":"

Phrase: "155 166,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Harlan DM,"

Phrase: "Hengartner H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Huang ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Kang YH,"

Phrase: "Abe R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Moreadith RW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035978:RW [Geographic Area]
   861   C2700310:RW [Fish]

Phrase: "Pircher H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Gray GS,"

Phrase: "Ohashi PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "Freeman GJ"

Phrase: ":"

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "both B7-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1366561:B7-1 [Gene or Genome]
  1000   C1705431:B7-1 [Gene or Genome]

Phrase: "and"

Phrase: "viral glycoprotein on pancreatic beta cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1325834:viral glycoprotein [Cell Component]
   753   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]

Phrase: "along with glycoprotein-specific transgenic T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0039194:T-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "develop"

Phrase: "diabetes due to a breakdown of T-lymphocyte unresponsiveness."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.229: Proc Natl Acad Sci U S A91 :3137 3141,1994[Abstract/Free FullText] Lang KS, Recher M, Junt T, Navarini AA, Harris NL, Freigang S, Odermatt B, Conrad C, Ittner LM, Bauer S, Luther SA, Uematsu S, Akira S, Hengartner H, Zinkernagel RM: Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. 

Phrase: "Proc Natl Acad Sci U S A91"

Phrase: ":"

Phrase: "3137 3141,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lang KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Recher M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Junt T,"

Phrase: "Navarini AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "Harris NL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027778:NL [Geographic Area]
   861   C0560008:nL [Quantitative Concept]

Phrase: "Freigang S,"

Phrase: "Odermatt B,"

Phrase: "Conrad C,"

Phrase: "Ittner LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Bauer S,"

Phrase: "Luther SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Uematsu S,"

Phrase: "Akira S,"

Phrase: "Hengartner H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Zinkernagel RM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: ":"

Phrase: "Toll-like receptor engagement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0425152:engagement [Finding]
   812   C2937292:engagement [Finding]
   756   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "converts"

Phrase: "T-cell autoreactivity into overt autoimmune disease."
Processing 00000000.tx.230: Nat Med11 :138 145,2005[Medline] Krause I, Valesini G, Scrivo R, Shoenfeld Y: Autoimmune aspects of cytokine and anticytokine therapies. 

Phrase: "Nat Med11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1825960:MED11 [Gene or Genome]

Phrase: ":"

Phrase: "138 145,"

Phrase: "2005"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Krause I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Valesini G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Scrivo R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Shoenfeld Y"

Phrase: ":"

Phrase: "Autoimmune aspects of cytokine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1547011:Aspect [Quantitative Concept]
   737   C1879746:Aspect [Qualitative Concept]

Phrase: "and"

Phrase: "anticytokine therapies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C0281178:Anticytokine Therapy [Therapeutic or Preventive Procedure]
   861   C0087111:therapies [Therapeutic or Preventive Procedure]
   827 E C0039798:therapy [Functional Concept]
   827 E C1363945:Therapy [Finding]
Processing 00000000.tx.231: Am J Med115 :390 397,2003[Medline] Steegmann JL, Requena MJ, Martin-Regueira P, De La Camara R, Casado F, Salvanes FR, Fernandez Ranada JM: High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon-alpha. 

Phrase: "Am"

Phrase: "J Med115"

Phrase: ":"

Phrase: "390 397,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Steegmann JL,"

Phrase: "Requena MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Martin-Regueira P,"

Phrase: "De La Camara R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205090:R- [Spatial Concept]
   812   C0684010:R. [Professional or Occupational Group]
   812   C2603358:R' [Clinical Attribute]

Phrase: "Casado F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Salvanes FR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2348513:Fr. [Conceptual Entity]
   861   C3538902:FR [Gene or Genome]

Phrase: "Fernandez Ranada JM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022337:JM [Geographic Area]

Phrase: ":"

Phrase: "High incidence of autoimmune alterations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "in chronic myeloid leukemia patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0030705:Patients [Patient or Disabled Group]
   756   C0023473:Chronic myeloid leukaemia [Neoplastic Process]
   756   C2984277:Chronic myeloid leukemia [Functional Concept]
   708   C1279296:Chronic leukaemia [Neoplastic Process]

Phrase: "treated with interferon-alpha."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0002199:Interferon Alfa [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C0751598:Interferon Alfa [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C1610033:Interferon Alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
   833   C2825023:Interferon alfa [Pharmacologic Substance]
   770   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0439095:Alpha [Intellectual Product]
   770   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   770   C2003941:Alpha [Intellectual Product]
   770   C2350010:Alpha [Qualitative Concept]
   737 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.232: Am J Hematol72 :170 176,2003[Medline] Fabbri C, Jaboli MF, Giovanelli S, Azzaroli F, Pezzoli A, Accogli E, Liva S, Nigro G, Miracolo A, Festi D, Colecchia A, Montagnani M, Roda E, Mazzella G: Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy. 

Phrase: "Am"

Phrase: "J Hematol72"

Phrase: ":"

Phrase: "170 176,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fabbri C,"

Phrase: "Jaboli MF,"

Phrase: "Giovanelli S,"

Phrase: "Azzaroli F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Pezzoli A,"

Phrase: "Accogli E,"

Phrase: "Liva S,"

Phrase: "Nigro G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Miracolo A,"

Phrase: "Festi D,"

Phrase: "Colecchia A,"

Phrase: "Montagnani M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Roda E,"

Phrase: "Mazzella G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Gastric autoimmune disorders in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0004364:Autoimmune disorders [Disease or Syndrome]
   797   C0038354:Gastric Disorders [Disease or Syndrome]
   760   C0012634:Disorders [Disease or Syndrome]

Phrase: "with chronic hepatitis C before,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0524910:Hepatitis C, Chronic [Disease or Syndrome]
   861   C0019189:Hepatitis, Chronic [Disease or Syndrome]
   861   C0019196:Hepatitis C [Disease or Syndrome]
   861   C0220847:Hepatitis C [Virus]
   812   C0019158:Hepatitis [Disease or Syndrome]
   812   C0019159:hepatitis [Disease or Syndrome]
   812   C0205191:chronic [Temporal Concept]
   812   C0795623:hepatitis [Immunologic Factor,Pharmacologic Substance]

Phrase: "during"

Phrase: "and after interferon-alpha therapy."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   806   C0002199:Interferon Alfa [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   806   C0751598:Interferon Alfa [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   806   C1610033:Interferon Alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
   806   C2825023:Interferon alfa [Pharmacologic Substance]
   797   C0279030:interferon therapy [Therapeutic or Preventive Procedure]
   760   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0039798:therapy [Functional Concept]
   760   C0087111:Therapy [Therapeutic or Preventive Procedure]
   760   C0439095:Alpha [Intellectual Product]
   760   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1363945:Therapy [Finding]
   760   C1515981:And [Idea or Concept]
   760   C2003941:Alpha [Intellectual Product]
   760   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.233: World J Gastroenterol9 :1487 1490,2003[Medline] Preziati D, La Rosa L, Covini G, Marcelli R, Rescalli S, Persani L, Del Ninno E, Meroni PL, Colombo M, Beck-Peccoz P: Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. 

Phrase: "World J Gastroenterol9"

Phrase: ":"

Phrase: "1487 1490,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Preziati D,"

Phrase: "La Rosa L,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0035853:Rosa L. [Plant]

Phrase: "Covini G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Marcelli R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Rescalli S,"

Phrase: "Persani L,"

Phrase: "Del Ninno E,"

Phrase: "Meroni PL,"

Phrase: "Colombo M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Beck-Peccoz P"

Phrase: ":"

Phrase: "Autoimmunity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004368:Autoimmunity [Pathologic Function]
   928 E C0443146:Autoimmune [Pathologic Function]

Phrase: "and"

Phrase: "thyroid function in patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2242456:thyroid function [Physiologic Function]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "with chronic active hepatitis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0520463:Chronic active hepatitis [Disease or Syndrome]
   913   C0019189:Hepatitis, Chronic [Disease or Syndrome]
   901   C0332212:Chronic active [Functional Concept]
   901   C0744827:active hepatitis [Finding]
   827   C0019158:Hepatitis [Disease or Syndrome]
   827   C0019159:hepatitis [Disease or Syndrome]
   827   C0205177:Active [Functional Concept]
   827   C0205191:chronic [Temporal Concept]
   827   C0795623:hepatitis [Immunologic Factor,Pharmacologic Substance]

Phrase: "treated with recombinant interferon alpha-2a."
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   882   C0021734:Interferon Alfa-2a, Recombinant [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
           Interferon Alfa-2a
   833   C0751598:Recombinant Interferon Alfa [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Interferon Alfa
   820 E C1334080:alpha-2a interferon [Gene or Genome]
   790   C0002199:Interferon Alfa [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522537:Recombinant Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C1610033:Interferon Alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C2825023:Interferon alfa [Pharmacologic Substance]
   753   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0439095:Alpha [Intellectual Product]
   753   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C1514798:recombinant [Organism]
   753   C1522326:Treated [Functional Concept]
   753   C2003941:Alpha [Intellectual Product]
   753   C2350010:Alpha [Qualitative Concept]
   719 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.234: Eur J Endocrinol132 :587 593,1995[Abstract] Shimizu F, Shimizu M, Kamiyama K: Inhibitory effect of interferon on the production of insulin. 

Phrase: "Eur J Endocrinol132"

Phrase: ":"

Phrase: "587 593,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shimizu F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Shimizu M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kamiyama K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ":"

Phrase: "Inhibitory effect of interferon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "of insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.235: Endocrinology117 :2081 2084,1985[Abstract] Rhodes CJ, Taylor KW: Effect of human lymphoblastoid interferon on insulin synthesis and secretion in isolated human pancreatic islets. 

Phrase: "Endocrinology117"

Phrase: ":"

Phrase: "2081 2084,"

Phrase: "1985"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Rhodes CJ,"

Phrase: "Taylor KW"

Phrase: ":"

Phrase: "Effect of human lymphoblastoid interferon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on insulin synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "secretion in isolated human pancreatic islets."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0030296:Pancreatic Secretion [Body Substance]
   783   C0232787:Pancreatic secretion [Organ or Tissue Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
Processing 00000000.tx.236: Diabetologia27 :601 603,1984[Medline] Bonnevie-Nielsen V, Martensen PM, Justesen J, Kyvik KO, Kristensen B, Levin K, Beck-Nielsen H, Worsaa A, Dyrberg T: The antiviral 2',5'-oligoadenylate synthetase is persistently activated in type 1 diabetes. 

Phrase: "Diabetologia27"

Phrase: ":"

Phrase: "601 603,"

Phrase: "1984"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bonnevie-Nielsen V,"

Phrase: "Martensen PM, Justesen J,"

Phrase: "Kyvik KO,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416746:KO [Gene or Genome]
   861   C1862225:Ko [Body System]

Phrase: "Kristensen B,"

Phrase: "Levin K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Beck-Nielsen H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Worsaa A,"

Phrase: "Dyrberg T"

Phrase: ":"

Phrase: "The antiviral 2',"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003451:Antiviral [Pharmacologic Substance]

Phrase: "5'-oligoadenylate synthetase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023689:Synthetase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "persistently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750508:persistently [Idea or Concept]

Phrase: "activated in type 1 diabetes."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0011854:Type 1 diabetes [Disease or Syndrome]
   806   C0441729:Type 1 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   760   C1879547:Activated [Activity]
   726 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.237: Clin Immunol96 :11 18,2000[Medline] Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL: Immune interferon in the circulation of patients with autoimmune disease. 

Phrase: "Clin Immunol96"

Phrase: ":"

Phrase: "11 18,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hooks JJ,"

Phrase: "Moutsopoulos HM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0262500:hm [Health Care Activity]
   861   C1512358:HM [Geographic Area]
   861   C3538713:HM [Idea or Concept]

Phrase: "Geis SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Stahl NI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348274:Ni [Element, Ion, or Isotope]

Phrase: "Decker JL,"

Phrase: "Notkins AL"

Phrase: ":"

Phrase: "Immune interferon in the circulation of patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0021745:Interferon, Immune [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0439662:Immune [Functional Concept]
   748   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "with autoimmune disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004364:Autoimmune Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0443146:Autoimmune [Pathologic Function]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.238: N Engl J Med301 :5 8,1979[Abstract] Chehadeh W, Weill J, Vantyghem MX, Alm G, Lefebvre J, Wattre P, Hober D: Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. 

Phrase: "N Engl J Med301"

Phrase: ":"

Phrase: "5 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "1979"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Chehadeh W,"

Phrase: "Weill J,"

Phrase: "Vantyghem MX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025885:MX [Geographic Area]
   861   C0445039:MX [Finding]
   861   C1551087:Mx [Quantitative Concept]

Phrase: "Alm G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Lefebvre J,"

Phrase: "Wattre P,"

Phrase: "Hober D"

Phrase: ":"

Phrase: "Increased level of interferon-alpha"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with insulin-dependent diabetes mellitus"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "relationship with coxsackievirus B infection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.239: J Infect Dis181 :1929 1939,2000[Medline] Foulis AK, Farquharson MA, Hardman R: Aberrant expression of class II major histocompatibility complex molecules by  cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin dependent) diabetes mellitus. 

Phrase: "J"

Phrase: "Infect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:infect [Functional Concept]

Phrase: "Dis181"

Phrase: ":"

Phrase: "1929 1939,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Foulis AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: "Farquharson MA,"

Phrase: "Hardman R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Aberrant expression of class II major histocompatibility complex molecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by  cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "hyperexpression of class I major histocompatibility complex molecules"

Phrase: "by insulin containing islets"

Phrase: "in type 1 (insulin dependent) diabetes mellitus."
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   913   C0011854:Diabetes Mellitus, Type 1 [Disease or Syndrome]
           Diabetes Mellitus, Insulin-Dependent
           Type 1 diabetes
           Insulin Dependent Diabetes
   876   C1320657:type diabetes [Finding]
   827   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   827   C0441729:Type 1 [Classification]
   799   C0011847:Diabetes [Disease or Syndrome]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0332307:Type [Qualitative Concept]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1547052:*Type [Quantitative Concept]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1701901:Dependent [Qualitative Concept]
   799   C3244310:dependent [Functional Concept]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.240: Diabetologia30 :333 343,1987[Medline] This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Devendra, D. 

Phrase: "Diabetologia30"

Phrase: ":"

Phrase: "333 343,"

Phrase: "1987"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0557854:Services [Occupational Activity]
   966 E C2825316:Service [Manufactured Object]
   966 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Request Permissions Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1706852:Article [Intellectual Product]

Phrase: "by Devendra,"

Phrase: "D."
Processing 00000000.tx.241: Articles by Liu, E. 

Phrase: "Articles by Liu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "E."
Processing 00000000.tx.242: Articles citing this Article PubMed PubMed Citation Articles by Devendra, D. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Devendra,"

Phrase: "D."
Processing 00000000.tx.243: Articles by Liu, E. 

Phrase: "Articles by Liu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "E."
Processing 00000000.tx.244: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum DOC News

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Diabetes Diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0039224:Table [Manufactured Object]
   738   C1706073:Table [Medical Device]
   738   C1706074:Table [Intellectual Product]

Phrase: "Care"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947933:Care [Activity]

Phrase: "Clinical Diabetes Diabetes Spectrum DOC News"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0282425:News [Intellectual Product]

